Category,ID,Description,BgRatio,pvalue,padjust,qvalue,geneID,gene_name,rankScore,Gene Count
BP,GO:0010288,response to lead ion,24/18493,3.93E-09,3.45E-06,1.24E-06,351/4137/23621/5743,"APP,MAPT,BACE1,PTGS2",0.215394591,4
BP,GO:0070997,neuron death,335/18493,5.98E-09,3.45E-06,1.24E-06,351/4137/836/2932/23621/596/581,"APP,MAPT,CASP3,GSK3B,BACE1,BCL2,BAX",0.331272348,7
BP,GO:1901216,positive regulation of neuron death,81/18493,5.98E-09,3.45E-06,1.24E-06,4137/836/2932/23621/581,"MAPT,CASP3,GSK3B,BACE1,BAX",0.243780951,5
BP,GO:0050435,amyloid-beta metabolic process,37/18493,2.43E-08,1.05E-05,3.76E-06,351/1636/23621/102,"APP,ACE,BACE1,ADAM10",0.171712976,4
BP,GO:0006979,response to oxidative stress,441/18493,3.97E-08,1.37E-05,4.93E-06,351/4137/836/4846/596/4353/5743,"APP,MAPT,CASP3,NOS3,BCL2,MPO,PTGS2",0.322663842,7
BP,GO:0072593,reactive oxygen species metabolic process,276/18493,7.39E-08,2.13E-05,7.64E-06,4137/4846/596/4353/4843/5743,"MAPT,NOS3,BCL2,MPO,NOS2,PTGS2",0.216971943,6
BP,GO:1901214,regulation of neuron death,296/18493,1.12E-07,2.76E-05,9.91E-06,4137/836/2932/23621/596/581,"MAPT,CASP3,GSK3B,BACE1,BCL2,BAX",0.22284389,6
BP,GO:0001505,regulation of neurotransmitter levels,346/18493,2.81E-07,4.04E-05,1.45E-05,2932/23621/4846/43/4843/5743,"GSK3B,BACE1,NOS3,ACHE,NOS2,PTGS2",0.22206761,6
BP,GO:0070482,response to oxygen levels,349/18493,2.95E-07,4.04E-05,1.45E-05,836/5328/596/4843/5743/5468,"CASP3,PLAU,BCL2,NOS2,PTGS2,PPARG",0.213846767,6
BP,GO:0008217,regulation of blood pressure,177/18493,3.04E-07,4.04E-05,1.45E-05,1636/4846/4843/5743/5468,"ACE,NOS3,NOS2,PTGS2,PPARG",0.1873786,5
BP,GO:0045862,positive regulation of proteolysis,352/18493,3.11E-07,4.04E-05,1.45E-05,351/4137/836/2932/581/5468,"APP,MAPT,CASP3,GSK3B,BAX,PPARG",0.246052169,6
BP,GO:0006801,superoxide metabolic process,69/18493,3.12E-07,4.04E-05,1.45E-05,4137/4846/4353/4843,"MAPT,NOS3,MPO,NOS2",0.135638706,4
BP,GO:0010038,response to metal ion,358/18493,3.43E-07,4.04E-05,1.45E-05,351/4137/836/23621/596/5743,"APP,MAPT,CASP3,BACE1,BCL2,PTGS2",0.257082252,6
BP,GO:0038034,signal transduction in absence of ligand,71/18493,3.51E-07,4.04E-05,1.45E-05,836/2932/596/581,"CASP3,GSK3B,BCL2,BAX",0.142930416,4
BP,GO:0097192,extrinsic apoptotic signaling pathway in absence of ligand,71/18493,3.51E-07,4.04E-05,1.45E-05,836/2932/596/581,"CASP3,GSK3B,BCL2,BAX",0.142930416,4
BP,GO:0051098,regulation of binding,369/18493,4.10E-07,4.29E-05,1.54E-05,351/2932/1636/596/581/5468,"APP,GSK3B,ACE,BCL2,BAX,PPARG",0.197570049,6
BP,GO:0010952,positive regulation of peptidase activity,189/18493,4.22E-07,4.29E-05,1.54E-05,351/4137/836/581/5468,"APP,MAPT,CASP3,BAX,PPARG",0.208973422,5
BP,GO:0010042,response to manganese ion,20/18493,6.00E-07,5.73E-05,2.06E-05,351/23621/5743,"APP,BACE1,PTGS2",0.133134988,3
BP,GO:0009266,response to temperature stimulus,208/18493,6.77E-07,5.73E-05,2.06E-05,4137/2932/4846/5743/5468,"MAPT,GSK3B,NOS3,PTGS2,PPARG",0.188056257,5
BP,GO:0043281,regulation of cysteine-type endopeptidase activity involved in apoptotic process,209/18493,6.94E-07,5.73E-05,2.06E-05,4137/836/581/5743/5468,"MAPT,CASP3,BAX,PTGS2,PPARG",0.201052237,5
BP,GO:0032469,endoplasmic reticulum calcium ion homeostasis,22/18493,8.10E-07,5.73E-05,2.06E-05,351/596/581,"APP,BCL2,BAX",0.090380392,3
BP,GO:0006919,activation of cysteine-type endopeptidase activity involved in apoptotic process,88/18493,8.34E-07,5.73E-05,2.06E-05,4137/836/581/5468,"MAPT,CASP3,BAX,PPARG",0.153045437,4
BP,GO:0043393,regulation of protein binding,217/18493,8.35E-07,5.73E-05,2.06E-05,351/2932/1636/596/581,"APP,GSK3B,ACE,BCL2,BAX",0.158260395,5
BP,GO:0052548,regulation of endopeptidase activity,417/18493,8.39E-07,5.73E-05,2.06E-05,351/4137/836/581/5743/5468,"APP,MAPT,CASP3,BAX,PTGS2,PPARG",0.250939379,6
BP,GO:0050804,modulation of chemical synaptic transmission,418/18493,8.50E-07,5.73E-05,2.06E-05,351/4137/2932/23621/43/5743,"APP,MAPT,GSK3B,BACE1,ACHE,PTGS2",0.232372409,6
BP,GO:0099177,regulation of trans-synaptic signaling,419/18493,8.62E-07,5.73E-05,2.06E-05,351/4137/2932/23621/43/5743,"APP,MAPT,GSK3B,BACE1,ACHE,PTGS2",0.232372409,6
BP,GO:0048608,reproductive structure development,428/18493,9.76E-07,5.82E-05,2.09E-05,836/4846/596/581/5743/5468,"CASP3,NOS3,BCL2,BAX,PTGS2,PPARG",0.222354854,6
BP,GO:0000302,response to reactive oxygen species,224/18493,9.77E-07,5.82E-05,2.09E-05,4137/836/4846/596/4353,"MAPT,CASP3,NOS3,BCL2,MPO",0.183297079,5
BP,GO:0097191,extrinsic apoptotic signaling pathway,224/18493,9.77E-07,5.82E-05,2.09E-05,836/2932/4846/596/581,"CASP3,GSK3B,NOS3,BCL2,BAX",0.175431302,5
BP,GO:0061458,reproductive system development,431/18493,1.02E-06,5.86E-05,2.10E-05,836/4846/596/581/5743/5468,"CASP3,NOS3,BCL2,BAX,PTGS2,PPARG",0.222216145,6
BP,GO:0051402,neuron apoptotic process,230/18493,1.11E-06,6.06E-05,2.18E-05,351/836/23621/596/581,"APP,CASP3,BACE1,BCL2,BAX",0.187414885,5
BP,GO:2000116,regulation of cysteine-type endopeptidase activity,232/18493,1.16E-06,6.06E-05,2.18E-05,4137/836/581/5743/5468,"MAPT,CASP3,BAX,PTGS2,PPARG",0.199887631,5
BP,GO:0052547,regulation of peptidase activity,442/18493,1.18E-06,6.06E-05,2.18E-05,351/4137/836/581/5743/5468,"APP,MAPT,CASP3,BAX,PTGS2,PPARG",0.249485799,6
BP,GO:0009314,response to radiation,443/18493,1.19E-06,6.06E-05,2.18E-05,351/836/23621/596/581/5743,"APP,CASP3,BACE1,BCL2,BAX,PTGS2",0.235143603,6
BP,GO:0008585,female gonad development,98/18493,1.29E-06,6.34E-05,2.28E-05,836/4846/596/581,"CASP3,NOS3,BCL2,BAX",0.139635296,4
BP,GO:0042136,neurotransmitter biosynthetic process,102/18493,1.51E-06,7.24E-05,2.60E-05,4846/43/4843/5743,"NOS3,ACHE,NOS2,PTGS2",0.14107447,4
BP,GO:0046545,development of primary female sexual characteristics,103/18493,1.57E-06,7.33E-05,2.63E-05,836/4846/596/581,"CASP3,NOS3,BCL2,BAX",0.137556118,4
BP,GO:1904646,cellular response to amyloid-beta,28/18493,1.72E-06,7.81E-05,2.80E-05,351/2932/23621,"APP,GSK3B,BACE1",0.115937601,3
BP,GO:0016049,cell growth,485/18493,2.02E-06,8.95E-05,3.21E-05,351/4137/2932/596/102/5468,"APP,MAPT,GSK3B,BCL2,ADAM10,PPARG",0.189077188,6
BP,GO:0001782,B cell homeostasis,30/18493,2.13E-06,9.19E-05,3.30E-05,836/596/581,"CASP3,BCL2,BAX",0.098383171,3
BP,GO:0048873,homeostasis of number of cells within a tissue,31/18493,2.35E-06,9.68E-05,3.47E-05,4846/596/581,"NOS3,BCL2,BAX",0.07401983,3
BP,GO:1904645,response to amyloid-beta,31/18493,2.35E-06,9.68E-05,3.47E-05,351/2932/23621,"APP,GSK3B,BACE1",0.11330586,3
BP,GO:1903409,reactive oxygen species biosynthetic process,115/18493,2.44E-06,9.80E-05,3.52E-05,4846/4353/4843/5743,"NOS3,MPO,NOS2,PTGS2",0.136884274,4
BP,GO:1901030,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,32/18493,2.60E-06,0.000101933,3.66E-05,2932/596/581,"GSK3B,BCL2,BAX",0.070672371,3
BP,GO:0046660,female sex differentiation,118/18493,2.70E-06,0.000102416,3.67E-05,836/4846/596/581,"CASP3,NOS3,BCL2,BAX",0.132717951,4
BP,GO:0048511,rhythmic process,276/18493,2.73E-06,0.000102416,3.67E-05,836/2932/4846/4843/5468,"CASP3,GSK3B,NOS3,NOS2,PPARG",0.185391697,5
BP,GO:0018105,peptidyl-serine phosphorylation,282/18493,3.03E-06,0.000111369,4.00E-05,351/2932/596/581/5743,"APP,GSK3B,BCL2,BAX,PTGS2",0.16122695,5
BP,GO:0043280,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,126/18493,3.51E-06,0.000126339,4.53E-05,4137/836/581/5468,"MAPT,CASP3,BAX,PPARG",0.140659149,4
BP,GO:0018209,peptidyl-serine modification,301/18493,4.17E-06,0.000146928,5.27E-05,351/2932/596/581/5743,"APP,GSK3B,BCL2,BAX,PTGS2",0.156319016,5
BP,GO:0033135,regulation of peptidyl-serine phosphorylation,135/18493,4.62E-06,0.000155348,5.57E-05,351/596/581/5743,"APP,BCL2,BAX,PTGS2",0.124258468,4
BP,GO:0009416,response to light stimulus,308/18493,4.66E-06,0.000155348,5.57E-05,351/836/596/581/5743,"APP,CASP3,BCL2,BAX,PTGS2",0.18072353,5
BP,GO:0009411,response to UV,136/18493,4.76E-06,0.000155348,5.57E-05,836/596/581/5743,"CASP3,BCL2,BAX,PTGS2",0.135929646,4
BP,GO:0043029,T cell homeostasis,39/18493,4.76E-06,0.000155348,5.57E-05,836/596/581,"CASP3,BCL2,BAX",0.092824129,3
BP,GO:0001666,response to hypoxia,314/18493,5.12E-06,0.00016387,5.88E-05,836/5328/596/4843/5743,"CASP3,PLAU,BCL2,NOS2,PTGS2",0.154257403,5
BP,GO:1901028,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,41/18493,5.55E-06,0.000174186,6.25E-05,2932/596/581,"GSK3B,BCL2,BAX",0.066552514,3
BP,GO:0062013,positive regulation of small molecule metabolic process,142/18493,5.64E-06,0.000174186,6.25E-05,4846/4843/5743/5468,"NOS3,NOS2,PTGS2,PPARG",0.130820879,4
BP,GO:2001056,positive regulation of cysteine-type endopeptidase activity,143/18493,5.80E-06,0.000175963,6.31E-05,4137/836/581/5468,"MAPT,CASP3,BAX,PPARG",0.135467701,4
BP,GO:0032496,response to lipopolysaccharide,324/18493,5.97E-06,0.000176634,6.34E-05,836/4846/4353/4843/5743,"CASP3,NOS3,MPO,NOS2,PTGS2",0.183781892,5
BP,GO:0036293,response to decreased oxygen levels,325/18493,6.06E-06,0.000176634,6.34E-05,836/5328/596/4843/5743,"CASP3,PLAU,BCL2,NOS2,PTGS2",0.152929917,5
BP,GO:0009408,response to heat,145/18493,6.13E-06,0.000176634,6.34E-05,4137/2932/4846/5743,"MAPT,GSK3B,NOS3,PTGS2",0.136657613,4
BP,GO:0042133,neurotransmitter metabolic process,148/18493,6.65E-06,0.000188435,6.76E-05,4846/43/4843/5743,"NOS3,ACHE,NOS2,PTGS2",0.126922851,4
BP,GO:0001974,blood vessel remodeling,44/18493,6.89E-06,0.00019194,6.89E-05,1636/4846/581,"ACE,NOS3,BAX",0.081879786,3
BP,GO:0002237,response to molecule of bacterial origin,337/18493,7.22E-06,0.000198153,7.11E-05,836/4846/4353/4843/5743,"CASP3,NOS3,MPO,NOS2,PTGS2",0.181337011,5
BP,GO:0043525,positive regulation of neuron apoptotic process,48/18493,8.97E-06,0.000242319,8.69E-05,836/23621/581,"CASP3,BACE1,BAX",0.102772262,3
BP,GO:0062012,regulation of small molecule metabolic process,355/18493,9.30E-06,0.000247264,8.87E-05,2932/4846/4843/5743/5468,"GSK3B,NOS3,NOS2,PTGS2,PPARG",0.154952463,5
BP,GO:0042982,amyloid precursor protein metabolic process,49/18493,9.56E-06,0.000250168,8.98E-05,351/102/43,"APP,ADAM10,ACHE",0.091929722,3
BP,GO:0097345,mitochondrial outer membrane permeabilization,51/18493,1.08E-05,0.000278256,9.98E-05,2932/596/581,"GSK3B,BCL2,BAX",0.062950774,3
BP,GO:0010950,positive regulation of endopeptidase activity,171/18493,1.18E-05,0.000299308,0.000107391,4137/836/581/5468,"MAPT,CASP3,BAX,PPARG",0.127143981,4
BP,GO:0010821,regulation of mitochondrion organization,176/18493,1.32E-05,0.000330484,0.000118577,4137/2932/596/581,"MAPT,GSK3B,BCL2,BAX",0.08962571,4
BP,GO:0051099,positive regulation of binding,181/18493,1.47E-05,0.000361283,0.000129627,351/2932/1636/5468,"APP,GSK3B,ACE,PPARG",0.122831957,4
BP,GO:2001233,regulation of apoptotic signaling pathway,391/18493,1.48E-05,0.000361283,0.000129627,2932/4846/596/581/5743,"GSK3B,NOS3,BCL2,BAX,PTGS2",0.130514849,5
BP,GO:1902110,positive regulation of mitochondrial membrane permeability involved in apoptotic process,57/18493,1.51E-05,0.000362661,0.000130121,2932/596/581,"GSK3B,BCL2,BAX",0.060913707,3
BP,GO:1902686,mitochondrial outer membrane permeabilization involved in programmed cell death,59/18493,1.68E-05,0.000396992,0.000142439,2932/596/581,"GSK3B,BCL2,BAX",0.060218248,3
BP,GO:0035794,positive regulation of mitochondrial membrane permeability,61/18493,1.85E-05,0.000433104,0.000155396,2932/596/581,"GSK3B,BCL2,BAX",0.059548807,3
BP,GO:0001558,regulation of cell growth,416/18493,2.00E-05,0.00045878,0.000164608,4137/2932/596/102/5468,"MAPT,GSK3B,BCL2,ADAM10,PPARG",0.116667099,5
BP,GO:1902108,regulation of mitochondrial membrane permeability involved in apoptotic process,63/18493,2.04E-05,0.00045878,0.000164608,2932/596/581,"GSK3B,BCL2,BAX",0.059105979,3
BP,GO:1905710,positive regulation of membrane permeability,63/18493,2.04E-05,0.00045878,0.000164608,2932/596/581,"GSK3B,BCL2,BAX",0.059105979,3
BP,GO:0002260,lymphocyte homeostasis,64/18493,2.14E-05,0.000474921,0.0001704,836/596/581,"CASP3,BCL2,BAX",0.080996212,3
BP,GO:0042391,regulation of membrane potential,424/18493,2.19E-05,0.000479839,0.000172165,351/4137/2932/596/581,"APP,MAPT,GSK3B,BCL2,BAX",0.124489409,5
BP,GO:0051926,negative regulation of calcium ion transport,65/18493,2.25E-05,0.000484072,0.000173683,4846/596/5743,"NOS3,BCL2,PTGS2",0.08111006,3
BP,GO:0043523,regulation of neuron apoptotic process,202/18493,2.27E-05,0.000484072,0.000173683,836/23621/596/581,"CASP3,BACE1,BCL2,BAX",0.108336379,4
BP,GO:0009612,response to mechanical stimulus,204/18493,2.36E-05,0.000497017,0.000178328,23621/4353/5743/5468,"BACE1,MPO,PTGS2,PPARG",0.11500059,4
BP,GO:0050805,negative regulation of synaptic transmission,68/18493,2.57E-05,0.000529341,0.000189925,4137/43/5743,"MAPT,ACHE,PTGS2",0.0869994,3
BP,GO:0051881,regulation of mitochondrial membrane potential,68/18493,2.57E-05,0.000529341,0.000189925,4137/596/581,"MAPT,BCL2,BAX",0.057628394,3
BP,GO:0008406,gonad development,216/18493,2.95E-05,0.000599872,0.000215232,836/4846/596/581,"CASP3,NOS3,BCL2,BAX",0.107180188,4
BP,GO:0031284,positive regulation of guanylate cyclase activity,10/18493,3.15E-05,0.00062542,0.000224398,4846/4843,"NOS3,NOS2",0.049863147,2
BP,GO:0006809,nitric oxide biosynthetic process,73/18493,3.19E-05,0.00062542,0.000224398,4846/4843/5743,"NOS3,NOS2,PTGS2",0.086122999,3
BP,GO:0046902,regulation of mitochondrial membrane permeability,73/18493,3.19E-05,0.00062542,0.000224398,2932/596/581,"GSK3B,BCL2,BAX",0.056723468,3
BP,GO:0045137,development of primary sexual characteristics,222/18493,3.28E-05,0.000630668,0.000226282,836/4846/596/581,"CASP3,NOS3,BCL2,BAX",0.106456897,4
BP,GO:2001234,negative regulation of apoptotic signaling pathway,222/18493,3.28E-05,0.000630668,0.000226282,4846/596/581/5743,"NOS3,BCL2,BAX,PTGS2",0.095231736,4
BP,GO:0006970,response to osmotic stress,76/18493,3.59E-05,0.000682296,0.000244805,836/581/5743,"CASP3,BAX,PTGS2",0.099521278,3
BP,GO:0048871,multicellular organismal homeostasis,471/18493,3.63E-05,0.000682296,0.000244805,4846/596/43/581/5743,"NOS3,BCL2,ACHE,BAX,PTGS2",0.116989529,5
BP,GO:0046209,nitric oxide metabolic process,77/18493,3.74E-05,0.000694555,0.000249204,4846/4843/5743,"NOS3,NOS2,PTGS2",0.084898965,3
BP,GO:0010623,programmed cell death involved in cell development,11/18493,3.84E-05,0.000706359,0.000253439,596/581,"BCL2,BAX",0.030080263,2
BP,GO:1901652,response to peptide,481/18493,4.02E-05,0.000730574,0.000262127,351/2932/23621/5743/5468,"APP,GSK3B,BACE1,PTGS2,PPARG",0.148869904,5
BP,GO:2001057,reactive nitrogen species metabolic process,80/18493,4.19E-05,0.000754531,0.000270723,4846/4843/5743,"NOS3,NOS2,PTGS2",0.08393204,3
BP,GO:0090559,regulation of membrane permeability,81/18493,4.35E-05,0.000772656,0.000277226,2932/596/581,"GSK3B,BCL2,BAX",0.055097904,3
BP,GO:0051924,regulation of calcium ion transport,239/18493,4.38E-05,0.000772656,0.000277226,4846/596/581/5743,"NOS3,BCL2,BAX,PTGS2",0.092607516,4
BP,GO:0008015,blood circulation,492/18493,4.47E-05,0.000772766,0.000277266,1636/4846/4843/5743/5468,"ACE,NOS3,NOS2,PTGS2,PPARG",0.132713503,5
BP,GO:0061564,axon development,493/18493,4.52E-05,0.000772766,0.000277266,351/4137/836/2932/596,"APP,MAPT,CASP3,GSK3B,BCL2",0.146396653,5
BP,GO:0006527,arginine catabolic process,12/18493,4.61E-05,0.000772766,0.000277266,4846/4843,"NOS3,NOS2",0.04843322,2
BP,GO:0031282,regulation of guanylate cyclase activity,12/18493,4.61E-05,0.000772766,0.000277266,4846/4843,"NOS3,NOS2",0.04843322,2
BP,GO:0014910,regulation of smooth muscle cell migration,83/18493,4.68E-05,0.000772766,0.000277266,1636/5328/596,"ACE,PLAU,BCL2",0.049110436,3
BP,GO:0106027,neuron projection organization,83/18493,4.68E-05,0.000772766,0.000277266,351/2932/102,"APP,GSK3B,ADAM10",0.08243129,3
BP,GO:0090066,regulation of anatomical structure size,497/18493,4.70E-05,0.000772766,0.000277266,4137/2932/1636/4846/5743,"MAPT,GSK3B,ACE,NOS3,PTGS2",0.137728317,5
BP,GO:0003013,circulatory system process,500/18493,4.83E-05,0.000783442,0.000281096,1636/4846/4843/5743/5468,"ACE,NOS3,NOS2,PTGS2,PPARG",0.132459378,5
BP,GO:0008625,extrinsic apoptotic signaling pathway via death domain receptors,84/18493,4.85E-05,0.000783442,0.000281096,4846/596/581,"NOS3,BCL2,BAX",0.05727576,3
BP,GO:0007611,learning or memory,247/18493,4.98E-05,0.000797126,0.000286006,351/4137/836/5743,"APP,MAPT,CASP3,PTGS2",0.142366344,4
BP,GO:0048872,homeostasis of number of cells,248/18493,5.06E-05,0.000802342,0.000287877,836/4846/596/581,"CASP3,NOS3,BCL2,BAX",0.102978695,4
BP,GO:0017014,protein nitrosylation,13/18493,5.44E-05,0.000839902,0.000301354,1636/4843,"ACE,NOS2",0.044641062,2
BP,GO:0018119,peptidyl-cysteine S-nitrosylation,13/18493,5.44E-05,0.000839902,0.000301354,1636/4843,"ACE,NOS2",0.044641062,2
BP,GO:0071287,cellular response to manganese ion,13/18493,5.44E-05,0.000839902,0.000301354,351/23621,"APP,BACE1",0.061727901,2
BP,GO:0001776,leukocyte homeostasis,88/18493,5.58E-05,0.00085256,0.000305895,836/596/581,"CASP3,BCL2,BAX",0.07480329,3
BP,GO:0014909,smooth muscle cell migration,90/18493,5.96E-05,0.000903763,0.000324267,1636/5328/596,"ACE,PLAU,BCL2",0.04803721,3
BP,GO:0042100,B cell proliferation,91/18493,6.16E-05,0.000925958,0.00033223,836/596/581,"CASP3,BCL2,BAX",0.073929165,3
BP,GO:0048143,astrocyte activation,14/18493,6.35E-05,0.000945619,0.000339285,351/4137,"APP,MAPT",0.059893777,2
BP,GO:0015908,fatty acid transport,93/18493,6.58E-05,0.000971143,0.000348442,1636/4843/5468,"ACE,NOS2,PPARG",0.06758927,3
BP,GO:0032943,mononuclear cell proliferation,266/18493,6.65E-05,0.000973324,0.000349225,836/1636/596/581,"CASP3,ACE,BCL2,BAX",0.097025921,4
BP,GO:0032092,positive regulation of protein binding,94/18493,6.79E-05,0.000985351,0.00035354,351/2932/1636,"APP,GSK3B,ACE",0.083469209,3
BP,GO:0007548,sex differentiation,268/18493,6.84E-05,0.000985351,0.00035354,836/4846/596/581,"CASP3,NOS3,BCL2,BAX",0.100010343,4
BP,GO:0042447,hormone catabolic process,15/18493,7.32E-05,0.001036915,0.000372041,1636/43,"ACE,ACHE",0.044876315,2
BP,GO:1990000,amyloid fibril formation,15/18493,7.32E-05,0.001036915,0.000372041,351/4137,"APP,MAPT",0.059101074,2
BP,GO:0051348,negative regulation of transferase activity,274/18493,7.46E-05,0.00104757,0.000375864,4137/836/2932/5468,"MAPT,CASP3,GSK3B,PPARG",0.116058151,4
BP,GO:0048070,regulation of developmental pigmentation,16/18493,8.36E-05,0.001159107,0.000415883,596/581,"BCL2,BAX",0.028026864,2
BP,GO:0098869,cellular oxidant detoxification,101/18493,8.41E-05,0.001159107,0.000415883,4846/4353/5743,"NOS3,MPO,PTGS2",0.080664525,3
BP,GO:0070661,leukocyte proliferation,283/18493,8.45E-05,0.001159107,0.000415883,836/1636/596/581,"CASP3,ACE,BCL2,BAX",0.094581833,4
BP,GO:0050890,cognition,285/18493,8.69E-05,0.001177134,0.000422351,351/4137/836/5743,"APP,MAPT,CASP3,PTGS2",0.134587522,4
BP,GO:0014812,muscle cell migration,103/18493,8.91E-05,0.001177134,0.000422351,1636/5328/596,"ACE,PLAU,BCL2",0.046225978,3
BP,GO:0032091,negative regulation of protein binding,103/18493,8.91E-05,0.001177134,0.000422351,2932/1636/581,"GSK3B,ACE,BAX",0.062373662,3
BP,GO:0033138,positive regulation of peptidyl-serine phosphorylation,103/18493,8.91E-05,0.001177134,0.000422351,351/596/5743,"APP,BCL2,PTGS2",0.080065502,3
BP,GO:0097193,intrinsic apoptotic signaling pathway,287/18493,8.92E-05,0.001177134,0.000422351,836/596/581/5743,"CASP3,BCL2,BAX,PTGS2",0.104540204,4
BP,GO:0034599,cellular response to oxidative stress,289/18493,9.17E-05,0.001191939,0.000427663,4137/4846/596/4353,"MAPT,NOS3,BCL2,MPO",0.083198997,4
BP,GO:0034605,cellular response to heat,104/18493,9.17E-05,0.001191939,0.000427663,4137/2932/5743,"MAPT,GSK3B,PTGS2",0.080460199,3
BP,GO:0021761,limbic system development,105/18493,9.44E-05,0.001208181,0.000433491,836/2932/581,"CASP3,GSK3B,BAX",0.082502784,3
BP,GO:1990748,cellular detoxification,105/18493,9.44E-05,0.001208181,0.000433491,4846/4353/5743,"NOS3,MPO,PTGS2",0.080169736,3
BP,GO:0018107,peptidyl-threonine phosphorylation,109/18493,0.000105482,0.001340244,0.000480875,351/2932/596,"APP,GSK3B,BCL2",0.069449518,3
BP,GO:0010822,positive regulation of mitochondrion organization,112/18493,0.000114338,0.001442162,0.000517443,2932/596/581,"GSK3B,BCL2,BAX",0.050299381,3
BP,GO:0016485,protein processing,310/18493,0.000120207,0.001505198,0.000540059,836/1636/5328/102,"CASP3,ACE,PLAU,ADAM10",0.09291486,4
BP,GO:0007568,aging,311/18493,0.000121709,0.001513048,0.000542876,351/596/4353/5743,"APP,BCL2,MPO,PTGS2",0.097570137,4
BP,GO:0018210,peptidyl-threonine modification,116/18493,0.000126882,0.00156609,0.000561907,351/2932/596,"APP,GSK3B,BCL2",0.067814517,3
BP,GO:0001952,regulation of cell-matrix adhesion,117/18493,0.000130153,0.001591357,0.000570973,2932/5328/596,"GSK3B,PLAU,BCL2",0.045039148,3
BP,GO:0006525,arginine metabolic process,20/18493,0.000132138,0.001591357,0.000570973,4846/4843,"NOS3,NOS2",0.043550611,2
BP,GO:1902473,regulation of protein localization to synapse,20/18493,0.000132138,0.001591357,0.000570973,4137/102,"MAPT,ADAM10",0.040888933,2
BP,GO:1903829,positive regulation of cellular protein localization,318/18493,0.000132613,0.001591357,0.000570973,4137/2932/596/5743,"MAPT,GSK3B,BCL2,PTGS2",0.088913139,4
BP,GO:0008637,apoptotic mitochondrial changes,121/18493,0.000143783,0.001692901,0.000607407,2932/596/581,"GSK3B,BCL2,BAX",0.049066812,3
BP,GO:0030728,ovulation,21/18493,0.000145974,0.001692901,0.000607407,4846/5743,"NOS3,PTGS2",0.056014156,2
BP,GO:0031281,positive regulation of cyclase activity,21/18493,0.000145974,0.001692901,0.000607407,4846/4843,"NOS3,NOS2",0.043132511,2
BP,GO:0043496,regulation of protein homodimerization activity,21/18493,0.000145974,0.001692901,0.000607407,596/581,"BCL2,BAX",0.026456414,2
BP,GO:0051349,positive regulation of lyase activity,21/18493,0.000145974,0.001692901,0.000607407,4846/4843,"NOS3,NOS2",0.043132511,2
BP,GO:0098754,detoxification,123/18493,0.000150934,0.001729836,0.000620659,4846/4353/5743,"NOS3,MPO,PTGS2",0.075887052,3
BP,GO:0032102,negative regulation of response to external stimulus,329/18493,0.00015116,0.001729836,0.000620659,23621/5328/4846/5468,"BACE1,PLAU,NOS3,PPARG",0.079558928,4
BP,GO:0048638,regulation of developmental growth,334/18493,0.000160186,0.001821058,0.000653389,351/4137/2932/596,"APP,MAPT,GSK3B,BCL2",0.088267009,4
BP,GO:0035296,regulation of tube diameter,129/18493,0.000173765,0.001949782,0.000699575,1636/4846/5743,"ACE,NOS3,PTGS2",0.076032048,3
BP,GO:0097746,regulation of blood vessel diameter,129/18493,0.000173765,0.001949782,0.000699575,1636/4846/5743,"ACE,NOS3,PTGS2",0.076032048,3
BP,GO:0007006,mitochondrial membrane organization,131/18493,0.000181847,0.002027297,0.000727387,2932/596/581,"GSK3B,BCL2,BAX",0.047680767,3
BP,GO:0032800,receptor biosynthetic process,24/18493,0.000191561,0.002121903,0.000761331,43/5468,"ACHE,PPARG",0.040404761,2
BP,GO:0007292,female gamete generation,134/18493,0.000194421,0.002139871,0.000767778,4846/596/5743,"NOS3,BCL2,PTGS2",0.065317202,3
BP,GO:0072655,establishment of protein localization to mitochondrion,135/18493,0.000198735,0.002173506,0.000779846,4137/596/581,"MAPT,BCL2,BAX",0.046838445,3
BP,GO:0050880,regulation of blood vessel size,136/18493,0.00020311,0.002192801,0.000786769,1636/4846/5743,"ACE,NOS3,PTGS2",0.074600823,3
BP,GO:1901653,cellular response to peptide,356/18493,0.000204608,0.002192801,0.000786769,351/2932/23621/5468,"APP,GSK3B,BACE1,PPARG",0.096118957,4
BP,GO:0035150,regulation of tube size,137/18493,0.000207548,0.002192801,0.000786769,1636/4846/5743,"ACE,NOS3,PTGS2",0.074600823,3
BP,GO:0006309,apoptotic DNA fragmentation,25/18493,0.000208113,0.002192801,0.000786769,836/581,"CASP3,BAX",0.053489666,2
BP,GO:0019430,removal of superoxide radicals,25/18493,0.000208113,0.002192801,0.000786769,4846/4353,"NOS3,MPO",0.042963559,2
BP,GO:0034205,amyloid-beta formation,25/18493,0.000208113,0.002192801,0.000786769,351/102,"APP,ADAM10",0.048739605,2
BP,GO:0070585,protein localization to mitochondrion,139/18493,0.000216611,0.002268511,0.000813933,4137/596/581,"MAPT,BCL2,BAX",0.046511626,3
BP,GO:0071280,cellular response to copper ion,27/18493,0.000243247,0.002501966,0.000897696,351/23621,"APP,BACE1",0.052214098,2
BP,GO:0071450,cellular response to oxygen radical,27/18493,0.000243247,0.002501966,0.000897696,4846/4353,"NOS3,MPO",0.042038007,2
BP,GO:0071451,cellular response to superoxide,27/18493,0.000243247,0.002501966,0.000897696,4846/4353,"NOS3,MPO",0.042038007,2
BP,GO:0030900,forebrain development,374/18493,0.000247098,0.002526545,0.000906515,351/836/2932/581,"APP,CASP3,GSK3B,BAX",0.103992376,4
BP,GO:0010212,response to ionizing radiation,146/18493,0.000250348,0.002544718,0.000913035,836/596/581,"CASP3,BCL2,BAX",0.063228831,3
BP,GO:0010959,regulation of metal ion transport,376/18493,0.000252184,0.002548384,0.000914351,4846/596/581/5743,"NOS3,BCL2,BAX,PTGS2",0.077184544,4
BP,GO:0051604,protein maturation,378/18493,0.000257345,0.002585343,0.000927612,836/1636/5328/102,"CASP3,ACE,PLAU,ADAM10",0.085181037,4
BP,GO:0001844,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,28/18493,0.000261826,0.002585343,0.000927612,596/581,"BCL2,BAX",0.024700971,2
BP,GO:0007263,nitric oxide mediated signal transduction,28/18493,0.000261826,0.002585343,0.000927612,4846/4843,"NOS3,NOS2",0.040270571,2
BP,GO:0009065,glutamine family amino acid catabolic process,28/18493,0.000261826,0.002585343,0.000927612,4846/4843,"NOS3,NOS2",0.040270571,2
BP,GO:0051384,response to glucocorticoid,149/18493,0.00026579,0.002609576,0.000936306,836/596/5743,"CASP3,BCL2,PTGS2",0.078531537,3
BP,GO:0050808,synapse organization,384/18493,0.000273285,0.002668005,0.00095727,351/4137/102/43,"APP,MAPT,ADAM10,ACHE",0.086394748,4
BP,GO:0014074,response to purine-containing compound,151/18493,0.00027642,0.002683448,0.000962811,351/5743/5468,"APP,PTGS2,PPARG",0.079709229,3
BP,GO:0048545,response to steroid hormone,390/18493,0.000289928,0.002798855,0.001004219,836/596/5743/5468,"CASP3,BCL2,PTGS2,PPARG",0.097829274,4
BP,GO:0043271,negative regulation of ion transport,154/18493,0.000292875,0.002811603,0.001008793,4846/596/5743,"NOS3,BCL2,PTGS2",0.06241625,3
BP,GO:0000303,response to superoxide,30/18493,0.000301004,0.00285788,0.001025397,4846/4353,"NOS3,MPO",0.041104691,2
BP,GO:2000406,positive regulation of T cell migration,30/18493,0.000301004,0.00285788,0.001025397,351/102,"APP,ADAM10",0.04663083,2
BP,GO:0015718,monocarboxylic acid transport,158/18493,0.000315785,0.00296563,0.001064057,1636/4843/5468,"ACE,NOS2,PPARG",0.056712188,3
BP,GO:0043535,regulation of blood vessel endothelial cell migration,158/18493,0.000315785,0.00296563,0.001064057,4846/5743/5468,"NOS3,PTGS2,PPARG",0.071115949,3
BP,GO:0000305,response to oxygen radical,31/18493,0.0003216,0.002987769,0.001072001,4846/4353,"NOS3,MPO",0.040792797,2
BP,GO:0051204,protein insertion into mitochondrial membrane,31/18493,0.0003216,0.002987769,0.001072001,596/581,"BCL2,BAX",0.024101185,2
BP,GO:0003018,vascular process in circulatory system,161/18493,0.000333706,0.003067259,0.001100521,1636/4846/5743,"ACE,NOS3,PTGS2",0.070511632,3
BP,GO:2001242,regulation of intrinsic apoptotic signaling pathway,161/18493,0.000333706,0.003067259,0.001100521,596/581/5743,"BCL2,BAX,PTGS2",0.05243644,3
BP,GO:0034614,cellular response to reactive oxygen species,162/18493,0.000339823,0.003106956,0.001114764,4137/4846/4353,"MAPT,NOS3,MPO",0.060688276,3
BP,GO:0014002,astrocyte development,32/18493,0.000342867,0.003118286,0.00111883,351/4137,"APP,MAPT",0.049631202,2
BP,GO:0030307,positive regulation of cell growth,163/18493,0.000346012,0.003130414,0.001123181,4137/596/102,"MAPT,BCL2,ADAM10",0.047252001,3
BP,GO:0051100,negative regulation of binding,165/18493,0.000358608,0.003169578,0.001137233,2932/1636/581,"GSK3B,ACE,BAX",0.05321353,3
BP,GO:0006816,calcium ion transport,413/18493,0.000360555,0.003169578,0.001137233,4846/596/581/5743,"NOS3,BCL2,BAX,PTGS2",0.074365368,4
BP,GO:0000737,"DNA catabolic process, endonucleolytic",33/18493,0.000364803,0.003169578,0.001137233,836/581,"CASP3,BAX",0.050270989,2
BP,GO:0001774,microglial cell activation,33/18493,0.000364803,0.003169578,0.001137233,351/4137,"APP,MAPT",0.049490879,2
BP,GO:0002269,leukocyte activation involved in inflammatory response,33/18493,0.000364803,0.003169578,0.001137233,351/4137,"APP,MAPT",0.049490879,2
BP,GO:0042987,amyloid precursor protein catabolic process,33/18493,0.000364803,0.003169578,0.001137233,351/102,"APP,ADAM10",0.045806758,2
BP,GO:0048147,negative regulation of fibroblast proliferation,33/18493,0.000364803,0.003169578,0.001137233,581/5468,"BAX,PPARG",0.033016824,2
BP,GO:0031960,response to corticosteroid,166/18493,0.000365015,0.003169578,0.001137233,836/596/5743,"CASP3,BCL2,PTGS2",0.075964975,3
BP,GO:0021543,pallium development,169/18493,0.00038468,0.003307098,0.001186574,836/2932/581,"CASP3,GSK3B,BAX",0.07013769,3
BP,GO:0048469,cell maturation,169/18493,0.00038468,0.003307098,0.001186574,351/596/5468,"APP,BCL2,PPARG",0.059377066,3
BP,GO:0030262,apoptotic nuclear changes,34/18493,0.000387408,0.003314066,0.001189075,836/581,"CASP3,BAX",0.04988154,2
BP,GO:0048771,tissue remodeling,170/18493,0.000391383,0.003315248,0.001189499,1636/4846/581,"ACE,NOS3,BAX",0.054621646,3
BP,GO:2001235,positive regulation of apoptotic signaling pathway,170/18493,0.000391383,0.003315248,0.001189499,2932/596/581,"GSK3B,BCL2,BAX",0.043899026,3
BP,GO:0050727,regulation of inflammatory response,425/18493,0.000401951,0.003388157,0.001215658,351/4843/5743/5468,"APP,NOS2,PTGS2,PPARG",0.093043927,4
BP,GO:0045923,positive regulation of fatty acid metabolic process,35/18493,0.00041068,0.003422319,0.001227915,5743/5468,"PTGS2,PPARG",0.047436081,2
BP,GO:0071470,cellular response to osmotic stress,35/18493,0.00041068,0.003422319,0.001227915,836/5743,"CASP3,PTGS2",0.064460197,2
BP,GO:0048167,regulation of synaptic plasticity,173/18493,0.000411946,0.003422319,0.001227915,351/4137/5743,"APP,MAPT,PTGS2",0.076736753,3
BP,GO:0006921,cellular component disassembly involved in execution phase of apoptosis,36/18493,0.000434619,0.003559341,0.001277078,836/581,"CASP3,BAX",0.049257761,2
BP,GO:0034405,response to fluid shear stress,36/18493,0.000434619,0.003559341,0.001277078,4846/5743,"NOS3,PTGS2",0.049491062,2
BP,GO:2000403,positive regulation of lymphocyte migration,36/18493,0.000434619,0.003559341,0.001277078,351/102,"APP,ADAM10",0.044883508,2
BP,GO:1904951,positive regulation of establishment of protein localization,437/18493,0.000446663,0.003640725,0.001306279,2932/596/43/5743,"GSK3B,BCL2,ACHE,PTGS2",0.075419971,4
BP,GO:0019932,second-messenger-mediated signaling,439/18493,0.000454448,0.003686789,0.001322806,4137/2932/4846/4843,"MAPT,GSK3B,NOS3,NOS2",0.077296658,4
BP,GO:0043534,blood vessel endothelial cell migration,182/18493,0.00047778,0.003857959,0.001384221,4846/5743/5468,"NOS3,PTGS2,PPARG",0.06790206,3
BP,GO:0045687,positive regulation of glial cell differentiation,38/18493,0.00048449,0.003893948,0.001397134,351/5468,"APP,PPARG",0.047425545,2
BP,GO:0071248,cellular response to metal ion,184/18493,0.000493272,0.003940491,0.001413833,351/23621/5743,"APP,BACE1,PTGS2",0.075467849,3
BP,GO:0007409,axonogenesis,449/18493,0.000494842,0.003940491,0.001413833,351/4137/2932/596,"APP,MAPT,GSK3B,BCL2",0.077466668,4
BP,GO:2000377,regulation of reactive oxygen species metabolic process,185/18493,0.000501138,0.003972327,0.001425256,4137/596/5743,"MAPT,BCL2,PTGS2",0.056701396,3
BP,GO:0006308,DNA catabolic process,39/18493,0.000510421,0.004019157,0.001442059,836/581,"CASP3,BAX",0.048196309,2
BP,GO:0050769,positive regulation of neurogenesis,453/18493,0.000511698,0.004019157,0.001442059,351/4137/596/5468,"APP,MAPT,BCL2,PPARG",0.076620614,4
BP,GO:0071453,cellular response to oxygen levels,187/18493,0.000517112,0.004043301,0.001450721,596/5743/5468,"BCL2,PTGS2,PPARG",0.056226709,3
BP,GO:0051346,negative regulation of hydrolase activity,458/18493,0.000533343,0.004075577,0.001462302,351/2932/4846/5743,"APP,GSK3B,NOS3,PTGS2",0.095906116,4
BP,GO:0001990,regulation of systemic arterial blood pressure by hormone,40/18493,0.000537014,0.004075577,0.001462302,1636/4846,"ACE,NOS3",0.040001364,2
BP,GO:0030810,positive regulation of nucleotide biosynthetic process,40/18493,0.000537014,0.004075577,0.001462302,4846/4843,"NOS3,NOS2",0.037194096,2
BP,GO:0061900,glial cell activation,40/18493,0.000537014,0.004075577,0.001462302,351/4137,"APP,MAPT",0.047328495,2
BP,GO:1900373,positive regulation of purine nucleotide biosynthetic process,40/18493,0.000537014,0.004075577,0.001462302,4846/4843,"NOS3,NOS2",0.037194096,2
BP,GO:2000404,regulation of T cell migration,40/18493,0.000537014,0.004075577,0.001462302,351/102,"APP,ADAM10",0.043805343,2
BP,GO:0070838,divalent metal ion transport,459/18493,0.00053775,0.004075577,0.001462302,4846/596/581/5743,"NOS3,BCL2,BAX,PTGS2",0.071116154,4
BP,GO:0072511,divalent inorganic cation transport,462/18493,0.000551126,0.004158714,0.001492131,4846/596/581/5743,"NOS3,BCL2,BAX,PTGS2",0.070855178,4
BP,GO:0007623,circadian rhythm,193/18493,0.000566988,0.004259806,0.001528403,2932/4843/5468,"GSK3B,NOS2,PPARG",0.053928997,3
BP,GO:0010001,glial cell differentiation,194/18493,0.00057559,0.004305709,0.001544872,351/4137/5468,"APP,MAPT,PPARG",0.065596498,3
BP,GO:0006509,membrane protein ectodomain proteolysis,42/18493,0.000592184,0.004391817,0.001575768,23621/102,"BACE1,ADAM10",0.035070877,2
BP,GO:0042551,neuron maturation,42/18493,0.000592184,0.004391817,0.001575768,351/596,"APP,BCL2",0.037755764,2
BP,GO:0046688,response to copper ion,43/18493,0.000620757,0.004584055,0.001644742,351/23621,"APP,BACE1",0.046936564,2
BP,GO:1901215,negative regulation of neuron death,201/18493,0.000638155,0.004692474,0.001683642,2932/596/581,"GSK3B,BCL2,BAX",0.041227606,3
BP,GO:0031667,response to nutrient levels,481/18493,0.00064144,0.004696648,0.00168514,596/4353/5743/5468,"BCL2,MPO,PTGS2,PPARG",0.071609868,4
BP,GO:0032309,icosanoid secretion,44/18493,0.000649989,0.004719251,0.00169325,1636/4843,"ACE,NOS2",0.03376089,2
BP,GO:0048066,developmental pigmentation,44/18493,0.000649989,0.004719251,0.00169325,596/581,"BCL2,BAX",0.022205989,2
BP,GO:0018198,peptidyl-cysteine modification,45/18493,0.000679878,0.004874813,0.001749065,1636/4843,"ACE,NOS2",0.033556465,2
BP,GO:0045776,negative regulation of blood pressure,45/18493,0.000679878,0.004874813,0.001749065,4846/4843,"NOS3,NOS2",0.035983732,2
BP,GO:1900034,regulation of cellular response to heat,45/18493,0.000679878,0.004874813,0.001749065,4137/2932,"MAPT,GSK3B",0.037459462,2
BP,GO:0071241,cellular response to inorganic substance,207/18493,0.000695123,0.004963525,0.001780895,351/23621/5743,"APP,BACE1,PTGS2",0.072321644,3
BP,GO:0031279,regulation of cyclase activity,46/18493,0.000710424,0.004970089,0.00178325,4846/4843,"NOS3,NOS2",0.035852901,2
BP,GO:0045981,positive regulation of nucleotide metabolic process,46/18493,0.000710424,0.004970089,0.00178325,4846/4843,"NOS3,NOS2",0.035852901,2
BP,GO:0071715,icosanoid transport,46/18493,0.000710424,0.004970089,0.00178325,1636/4843,"ACE,NOS2",0.033434459,2
BP,GO:1900544,positive regulation of purine nucleotide metabolic process,46/18493,0.000710424,0.004970089,0.00178325,4846/4843,"NOS3,NOS2",0.035852901,2
BP,GO:1901571,fatty acid derivative transport,46/18493,0.000710424,0.004970089,0.00178325,1636/4843,"ACE,NOS2",0.033434459,2
BP,GO:0010810,regulation of cell-substrate adhesion,209/18493,0.000714812,0.004980623,0.001787029,2932/5328/596,"GSK3B,PLAU,BCL2",0.037063535,3
BP,GO:0002446,neutrophil mediated immunity,499/18493,0.000736326,0.005025592,0.001803164,1636/5328/102/4353,"ACE,PLAU,ADAM10,MPO",0.058295239,4
BP,GO:0008038,neuron recognition,47/18493,0.000741624,0.005025592,0.001803164,351/836,"APP,CASP3",0.061116852,2
BP,GO:0022602,ovulation cycle process,47/18493,0.000741624,0.005025592,0.001803164,836/4846,"CASP3,NOS3",0.054526407,2
BP,GO:0035094,response to nicotine,47/18493,0.000741624,0.005025592,0.001803164,836/596,"CASP3,BCL2",0.043862501,2
BP,GO:0051205,protein insertion into membrane,47/18493,0.000741624,0.005025592,0.001803164,596/581,"BCL2,BAX",0.021945239,2
BP,GO:0051339,regulation of lyase activity,47/18493,0.000741624,0.005025592,0.001803164,4846/4843,"NOS3,NOS2",0.035777837,2
BP,GO:0150076,neuroinflammatory response,47/18493,0.000741624,0.005025592,0.001803164,351/4137,"APP,MAPT",0.045526343,2
BP,GO:0003044,regulation of systemic arterial blood pressure mediated by a chemical signal,49/18493,0.000805986,0.005410543,0.001941283,1636/4846,"ACE,NOS3",0.037941688,2
BP,GO:1990090,cellular response to nerve growth factor stimulus,49/18493,0.000805986,0.005410543,0.001941283,351/4137,"APP,MAPT",0.044891544,2
BP,GO:0016358,dendrite development,218/18493,0.000807824,0.005410543,0.001941283,351/2932/102,"APP,GSK3B,ADAM10",0.060043308,3
BP,GO:0001894,tissue homeostasis,221/18493,0.000840461,0.005607401,0.002011915,4846/596/581,"NOS3,BCL2,BAX",0.041513743,3
BP,GO:0007160,cell-matrix adhesion,222/18493,0.000851524,0.005637679,0.002022778,2932/5328/596,"GSK3B,PLAU,BCL2",0.036197325,3
BP,GO:0010594,regulation of endothelial cell migration,222/18493,0.000851524,0.005637679,0.002022778,4846/5743/5468,"NOS3,PTGS2,PPARG",0.063267418,3
BP,GO:0048588,developmental cell growth,226/18493,0.000896707,0.005900121,0.002116941,351/4137/2932,"APP,MAPT,GSK3B",0.062333089,3
BP,GO:0030195,negative regulation of blood coagulation,52/18493,0.000907416,0.005900121,0.002116941,5328/4846,"PLAU,NOS3",0.028033381,2
BP,GO:1900047,negative regulation of hemostasis,52/18493,0.000907416,0.005900121,0.002116941,5328/4846,"PLAU,NOS3",0.028033381,2
BP,GO:1990089,response to nerve growth factor,52/18493,0.000907416,0.005900121,0.002116941,351/4137,"APP,MAPT",0.044146506,2
BP,GO:0060560,developmental growth involved in morphogenesis,227/18493,0.000908236,0.005900121,0.002116941,351/4137/2932,"APP,MAPT,GSK3B",0.062333089,3
BP,GO:0031669,cellular response to nutrient levels,228/18493,0.00091986,0.005953251,0.002136004,596/5743/5468,"BCL2,PTGS2,PPARG",0.052279336,3
BP,GO:0071216,cellular response to biotic stimulus,229/18493,0.000931578,0.006006593,0.002155143,2932/4846/4843,"GSK3B,NOS3,NOS2",0.052695788,3
BP,GO:0010332,response to gamma radiation,53/18493,0.000942525,0.006054587,0.002172363,596/581,"BCL2,BAX",0.021172967,2
BP,GO:0097237,cellular response to toxic substance,235/18493,0.00100389,0.006424895,0.002305229,4846/4353/5743,"NOS3,MPO,PTGS2",0.060229865,3
BP,GO:0001541,ovarian follicle development,56/18493,0.001051738,0.006657154,0.002388562,596/581,"BCL2,BAX",0.020779618,2
BP,GO:0019229,regulation of vasoconstriction,56/18493,0.001051738,0.006657154,0.002388562,1636/5743,"ACE,PTGS2",0.041709915,2
BP,GO:0050819,negative regulation of coagulation,56/18493,0.001051738,0.006657154,0.002388562,5328/4846,"PLAU,NOS3",0.027374057,2
BP,GO:0006839,mitochondrial transport,241/18493,0.001079682,0.00680909,0.002443076,2932/596/581,"GSK3B,BCL2,BAX",0.03836495,3
BP,GO:2001244,positive regulation of intrinsic apoptotic signaling pathway,57/18493,0.001089433,0.006845604,0.002456177,596/581,"BCL2,BAX",0.020663887,2
BP,GO:0001836,release of cytochrome c from mitochondria,58/18493,0.001127773,0.00706084,0.002533403,596/581,"BCL2,BAX",0.02053554,2
BP,GO:0030888,regulation of B cell proliferation,59/18493,0.001166756,0.007174924,0.002574336,836/596,"CASP3,BCL2",0.040912083,2
BP,GO:0033619,membrane protein proteolysis,59/18493,0.001166756,0.007174924,0.002574336,23621/102,"BACE1,ADAM10",0.031899457,2
BP,GO:0070059,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,59/18493,0.001166756,0.007174924,0.002574336,596/581,"BCL2,BAX",0.020469089,2
BP,GO:0072678,T cell migration,59/18493,0.001166756,0.007174924,0.002574336,351/102,"APP,ADAM10",0.039302968,2
BP,GO:2000401,regulation of lymphocyte migration,59/18493,0.001166756,0.007174924,0.002574336,351/102,"APP,ADAM10",0.039302968,2
BP,GO:0021537,telencephalon development,248/18493,0.001172593,0.007185249,0.002578041,836/2932/581,"CASP3,GSK3B,BAX",0.060609154,3
BP,GO:0045685,regulation of glial cell differentiation,62/18493,0.001287551,0.007861796,0.002820783,351/5468,"APP,PPARG",0.041419995,2
BP,GO:0034612,response to tumor necrosis factor,257/18493,0.001299306,0.007877898,0.002826561,836/102/5743,"CASP3,ADAM10,PTGS2",0.068812757,3
BP,GO:0045165,cell fate commitment,257/18493,0.001299306,0.007877898,0.002826561,836/596/5468,"CASP3,BCL2,PPARG",0.056799823,3
BP,GO:0031668,cellular response to extracellular stimulus,258/18493,0.001313898,0.007938514,0.00284831,596/5743/5468,"BCL2,PTGS2,PPARG",0.04934297,3
BP,GO:0031334,positive regulation of protein complex assembly,259/18493,0.001328593,0.007974573,0.002861247,4137/2932/581,"MAPT,GSK3B,BAX",0.045098683,3
BP,GO:0008088,axo-dendritic transport,63/18493,0.001329096,0.007974573,0.002861247,351/4137,"APP,MAPT",0.041555183,2
BP,GO:0032409,regulation of transporter activity,260/18493,0.001343391,0.00800476,0.002872078,351/596/5468,"APP,BCL2,PPARG",0.05018761,3
BP,GO:0045926,negative regulation of growth,260/18493,0.001343391,0.00800476,0.002872078,596/4353/5468,"BCL2,MPO,PPARG",0.040758462,3
BP,GO:0045600,positive regulation of fat cell differentiation,64/18493,0.001371278,0.008126936,0.002915914,5743/5468,"PTGS2,PPARG",0.040209962,2
BP,GO:1903522,regulation of blood circulation,262/18493,0.001373302,0.008126936,0.002915914,1636/4846/5743,"ACE,NOS3,PTGS2",0.058639013,3
BP,GO:0034976,response to endoplasmic reticulum stress,264/18493,0.00140363,0.00824991,0.002960037,2932/596/581,"GSK3B,BCL2,BAX",0.036889067,3
BP,GO:0046651,lymphocyte proliferation,264/18493,0.00140363,0.00824991,0.002960037,836/596/581,"CASP3,BCL2,BAX",0.050779563,3
BP,GO:0035418,protein localization to synapse,65/18493,0.001414098,0.008283257,0.002972002,4137/102,"MAPT,ADAM10",0.030420109,2
BP,GO:0042063,gliogenesis,266/18493,0.00143438,0.008345485,0.002994329,351/4137/5468,"APP,MAPT,PPARG",0.057628094,3
BP,GO:0043542,endothelial cell migration,266/18493,0.00143438,0.008345485,0.002994329,4846/5743/5468,"NOS3,PTGS2,PPARG",0.058474992,3
BP,GO:0045927,positive regulation of growth,267/18493,0.001449914,0.008395506,0.003012277,4137/596/102,"MAPT,BCL2,ADAM10",0.039168267,3
BP,GO:0014015,positive regulation of gliogenesis,66/18493,0.001457553,0.008395506,0.003012277,351/5468,"APP,PPARG",0.040858569,2
BP,GO:0015909,long-chain fatty acid transport,66/18493,0.001457553,0.008395506,0.003012277,1636/5468,"ACE,PPARG",0.032727625,2
BP,GO:0060485,mesenchyme development,269/18493,0.001481299,0.008503935,0.00305118,2932/4846/596,"GSK3B,NOS3,BCL2",0.0441153,3
BP,GO:0045454,cell redox homeostasis,67/18493,0.001501644,0.00856383,0.00307267,4846/4843,"NOS3,NOS2",0.032175159,2
BP,GO:0046824,positive regulation of nucleocytoplasmic transport,67/18493,0.001501644,0.00856383,0.00307267,2932/5743,"GSK3B,PTGS2",0.040263839,2
BP,GO:0001822,kidney development,271/18493,0.001513111,0.00857264,0.003075832,1636/596/581,"ACE,BCL2,BAX",0.035944307,3
BP,GO:0021700,developmental maturation,271/18493,0.001513111,0.00857264,0.003075832,351/596/5468,"APP,BCL2,PPARG",0.049475094,3
BP,GO:0031670,cellular response to nutrient,68/18493,0.001546368,0.008703989,0.003122959,5743/5468,"PTGS2,PPARG",0.039636818,2
BP,GO:0042698,ovulation cycle,68/18493,0.001546368,0.008703989,0.003122959,836/4846,"CASP3,NOS3",0.048868598,2
BP,GO:0040014,regulation of multicellular organism growth,69/18493,0.001591726,0.008901303,0.003193754,351/596,"APP,BCL2",0.032841859,2
BP,GO:0048708,astrocyte differentiation,69/18493,0.001591726,0.008901303,0.003193754,351/4137,"APP,MAPT",0.040609606,2
BP,GO:0048678,response to axon injury,70/18493,0.001637716,0.009099591,0.003264899,596/581,"BCL2,BAX",0.019483863,2
BP,GO:1903747,regulation of establishment of protein localization to mitochondrion,70/18493,0.001637716,0.009099591,0.003264899,4137/596,"MAPT,BCL2",0.025101008,2
BP,GO:0010632,regulation of epithelial cell migration,284/18493,0.001730436,0.00955969,0.003429981,4846/5743/5468,"NOS3,PTGS2,PPARG",0.056815387,3
BP,GO:0061045,negative regulation of wound healing,72/18493,0.001731587,0.00955969,0.003429981,5328/4846,"PLAU,NOS3",0.025397693,2
BP,GO:0072001,renal system development,286/18493,0.001765517,0.009715967,0.003486053,1636/596/581,"ACE,BCL2,BAX",0.034998757,3
BP,GO:0042310,vasoconstriction,73/18493,0.001779467,0.009730757,0.00349136,1636/5743,"ACE,PTGS2",0.038550923,2
BP,GO:1900371,regulation of purine nucleotide biosynthetic process,73/18493,0.001779467,0.009730757,0.00349136,4846/4843,"NOS3,NOS2",0.031311711,2
BP,GO:0030808,regulation of nucleotide biosynthetic process,74/18493,0.001827975,0.009964483,0.00357522,4846/4843,"NOS3,NOS2",0.031151279,2
BP,GO:0010769,regulation of cell morphogenesis involved in differentiation,293/18493,0.001891819,0.010280072,0.003688452,4137/2932/102,"MAPT,GSK3B,ADAM10",0.045268802,3
BP,GO:0072332,intrinsic apoptotic signaling pathway by p53 class mediator,76/18493,0.001926872,0.010437725,0.003745017,596/581,"BCL2,BAX",0.018915054,2
BP,GO:0032103,positive regulation of response to external stimulus,297/18493,0.001966474,0.010610876,0.003807143,351/102/5743,"APP,ADAM10,PTGS2",0.058531957,3
BP,GO:0030193,regulation of blood coagulation,77/18493,0.001977258,0.010610876,0.003807143,5328/4846,"PLAU,NOS3",0.024827912,2
BP,GO:1900046,regulation of hemostasis,77/18493,0.001977258,0.010610876,0.003807143,5328/4846,"PLAU,NOS3",0.024827912,2
BP,GO:0009064,glutamine family amino acid metabolic process,78/18493,0.002028269,0.010784149,0.003869313,4846/4843,"NOS3,NOS2",0.030616963,2
BP,GO:0021766,hippocampus development,78/18493,0.002028269,0.010784149,0.003869313,836/2932,"CASP3,GSK3B",0.04521421,2
BP,GO:0034644,cellular response to UV,78/18493,0.002028269,0.010784149,0.003869313,581/5743,"BAX,PTGS2",0.032673084,2
BP,GO:0043536,positive regulation of blood vessel endothelial cell migration,79/18493,0.002079902,0.010967981,0.003935271,4846/5743,"NOS3,PTGS2",0.039612434,2
BP,GO:0010506,regulation of autophagy,303/18493,0.002081885,0.010967981,0.003935271,4137/836/596,"MAPT,CASP3,BCL2",0.053159269,3
BP,GO:0042113,B cell activation,303/18493,0.002081885,0.010967981,0.003935271,836/596/581,"CASP3,BCL2,BAX",0.047765339,3
BP,GO:0042116,macrophage activation,80/18493,0.002132158,0.011164757,0.004005874,351/4137,"APP,MAPT",0.038660949,2
BP,GO:2000300,regulation of synaptic vesicle exocytosis,80/18493,0.002132158,0.011164757,0.004005874,2932/23621,"GSK3B,BACE1",0.032145461,2
BP,GO:0097756,negative regulation of blood vessel diameter,81/18493,0.002185036,0.011407075,0.004092816,1636/5743,"ACE,PTGS2",0.037228222,2
BP,GO:0050818,regulation of coagulation,82/18493,0.002238533,0.011616172,0.00416784,5328/4846,"PLAU,NOS3",0.024333531,2
BP,GO:0097194,execution phase of apoptosis,82/18493,0.002238533,0.011616172,0.00416784,836/581,"CASP3,BAX",0.03892407,2
BP,GO:0015849,organic acid transport,316/18493,0.002346302,0.012000832,0.004305854,1636/4843/5468,"ACE,NOS2,PPARG",0.043092232,3
BP,GO:0046942,carboxylic acid transport,316/18493,0.002346302,0.012000832,0.004305854,1636/4843/5468,"ACE,NOS2,PPARG",0.043092232,3
BP,GO:0050886,endocrine process,84/18493,0.002347385,0.012000832,0.004305854,1636/4846,"ACE,NOS3",0.032150731,2
BP,GO:0070542,response to fatty acid,84/18493,0.002347385,0.012000832,0.004305854,5743/5468,"PTGS2,PPARG",0.036953175,2
BP,GO:1903035,negative regulation of response to wounding,84/18493,0.002347385,0.012000832,0.004305854,5328/4846,"PLAU,NOS3",0.024155603,2
BP,GO:1902803,regulation of synaptic vesicle transport,85/18493,0.002402737,0.012213336,0.0043821,2932/23621,"GSK3B,BACE1",0.031503506,2
BP,GO:0071214,cellular response to abiotic stimulus,319/18493,0.002410155,0.012213336,0.0043821,836/581/5743,"CASP3,BAX,PTGS2",0.060138678,3
BP,GO:0104004,cellular response to environmental stimulus,319/18493,0.002410155,0.012213336,0.0043821,836/581/5743,"CASP3,BAX,PTGS2",0.060138678,3
BP,GO:0001655,urogenital system development,322/18493,0.002475085,0.012505692,0.004486996,1636/596/581,"ACE,BCL2,BAX",0.033092374,3
BP,GO:0048814,regulation of dendrite morphogenesis,87/18493,0.00251529,0.012634947,0.004533372,2932/102,"GSK3B,ADAM10",0.027959374,2
BP,GO:0061097,regulation of protein tyrosine kinase activity,87/18493,0.00251529,0.012634947,0.004533372,351/1636,"APP,ACE",0.03721901,2
BP,GO:0010721,negative regulation of cell development,326/18493,0.002563344,0.01283901,0.004606589,351/2932/596,"APP,GSK3B,BCL2",0.045725717,3
BP,GO:0019217,regulation of fatty acid metabolic process,88/18493,0.002572489,0.012847575,0.004609662,5743/5468,"PTGS2,PPARG",0.036383525,2
BP,GO:0071496,cellular response to external stimulus,328/18493,0.002608201,0.012988388,0.004660185,596/5743/5468,"BCL2,PTGS2,PPARG",0.044319633,3
BP,GO:0009791,post-embryonic development,89/18493,0.002630301,0.013023381,0.004672741,596/581,"BCL2,BAX",0.01799748,2
BP,GO:0033273,response to vitamin,89/18493,0.002630301,0.013023381,0.004672741,5743/5468,"PTGS2,PPARG",0.036269968,2
BP,GO:0003073,regulation of systemic arterial blood pressure,90/18493,0.002688725,0.013236802,0.004749316,1636/4846,"ACE,NOS3",0.031438153,2
BP,GO:0048145,regulation of fibroblast proliferation,90/18493,0.002688725,0.013236802,0.004749316,581/5468,"BAX,PPARG",0.024815043,2
BP,GO:0001101,response to acid chemical,332/18493,0.002699377,0.013251486,0.004754584,836/5743/5468,"CASP3,PTGS2,PPARG",0.063962903,3
BP,GO:0030516,regulation of axon extension,91/18493,0.002747761,0.013412802,0.004812464,4137/2932,"MAPT,GSK3B",0.030337732,2
BP,GO:0048144,fibroblast proliferation,91/18493,0.002747761,0.013412802,0.004812464,581/5468,"BAX,PPARG",0.024739253,2
BP,GO:0031589,cell-substrate adhesion,338/18493,0.002839827,0.013823158,0.004959698,2932/5328/596,"GSK3B,PLAU,BCL2",0.029927988,3
BP,GO:1900542,regulation of purine nucleotide metabolic process,94/18493,0.002928529,0.014214882,0.005100247,4846/4843,"NOS3,NOS2",0.028749993,2
BP,GO:0009165,nucleotide biosynthetic process,344/18493,0.002984744,0.014432185,0.005178214,4846/4843/5743,"NOS3,NOS2,PTGS2",0.04947951,3
BP,GO:0043473,pigmentation,95/18493,0.002990001,0.014432185,0.005178214,596/581,"BCL2,BAX",0.017571634,2
BP,GO:0010631,epithelial cell migration,346/18493,0.003034051,0.014604013,0.005239866,4846/5743/5468,"NOS3,PTGS2,PPARG",0.051638188,3
BP,GO:2001243,negative regulation of intrinsic apoptotic signaling pathway,96/18493,0.00305208,0.014642016,0.005253501,596/5743,"BCL2,PTGS2",0.028566835,2
BP,GO:1901293,nucleoside phosphate biosynthetic process,347/18493,0.003058893,0.014642016,0.005253501,4846/4843/5743,"NOS3,NOS2,PTGS2",0.049310996,3
BP,GO:0090132,epithelium migration,349/18493,0.003108956,0.014827312,0.005319985,4846/5743/5468,"NOS3,PTGS2,PPARG",0.051452788,3
BP,GO:0021782,glial cell development,97/18493,0.003114765,0.014827312,0.005319985,351/4137,"APP,MAPT",0.036220801,2
BP,GO:0001654,eye development,351/18493,0.003159526,0.014996406,0.005380655,596/43/581,"BCL2,ACHE,BAX",0.030533593,3
BP,GO:0006140,regulation of nucleotide metabolic process,98/18493,0.003178055,0.014996406,0.005380655,4846/4843,"NOS3,NOS2",0.028388233,2
BP,GO:2000379,positive regulation of reactive oxygen species metabolic process,98/18493,0.003178055,0.014996406,0.005380655,4137/5743,"MAPT,PTGS2",0.035314698,2
BP,GO:0150063,visual system development,352/18493,0.003185001,0.014996406,0.005380655,596/43/581,"BCL2,ACHE,BAX",0.030533593,3
BP,GO:0090130,tissue migration,355/18493,0.00326219,0.015318108,0.00549608,4846/5743/5468,"NOS3,PTGS2,PPARG",0.051054917,3
BP,GO:0010522,regulation of calcium ion transport into cytosol,100/18493,0.003306444,0.015395402,0.005523813,596/581,"BCL2,BAX",0.017303774,2
BP,GO:0050848,regulation of calcium-mediated signaling,100/18493,0.003306444,0.015395402,0.005523813,4137/2932,"MAPT,GSK3B",0.0293677,2
BP,GO:1901606,alpha-amino acid catabolic process,100/18493,0.003306444,0.015395402,0.005523813,4846/4843,"NOS3,NOS2",0.028210748,2
BP,GO:0048880,sensory system development,357/18493,0.003314288,0.015395402,0.005523813,596/43/581,"BCL2,ACHE,BAX",0.030342695,3
BP,GO:0006869,lipid transport,359/18493,0.003366899,0.015597861,0.005596455,1636/4843/5468,"ACE,NOS2,PPARG",0.040537964,3
BP,GO:0008630,intrinsic apoptotic signaling pathway in response to DNA damage,102/18493,0.003437241,0.015838808,0.005682906,596/581,"BCL2,BAX",0.017186054,2
BP,GO:0019233,sensory perception of pain,102/18493,0.003437241,0.015838808,0.005682906,23621/5743,"BACE1,PTGS2",0.035331863,2
BP,GO:0060079,excitatory postsynaptic potential,103/18493,0.00350354,0.016101377,0.005777114,351/2932,"APP,GSK3B",0.035718439,2
BP,GO:0017158,regulation of calcium ion-dependent exocytosis,104/18493,0.003570438,0.016322004,0.005856275,2932/23621,"GSK3B,BACE1",0.029429705,2
BP,GO:2001237,negative regulation of extrinsic apoptotic signaling pathway,104/18493,0.003570438,0.016322004,0.005856275,4846/596,"NOS3,BCL2",0.023500704,2
BP,GO:0043467,regulation of generation of precursor metabolites and energy,105/18493,0.003637935,0.016456416,0.005904501,2932/4843,"GSK3B,NOS2",0.026448388,2
BP,GO:0050905,neuromuscular process,105/18493,0.003637935,0.016456416,0.005904501,351/23621,"APP,BACE1",0.03579651,2
BP,GO:0061387,regulation of extent of cell growth,105/18493,0.003637935,0.016456416,0.005904501,4137/2932,"MAPT,GSK3B",0.028898749,2
BP,GO:0072676,lymphocyte migration,105/18493,0.003637935,0.016456416,0.005904501,351/102,"APP,ADAM10",0.032694657,2
BP,GO:0043900,regulation of multi-organism process,371/18493,0.00369344,0.016633808,0.005968149,596/4353/4843,"BCL2,MPO,NOS2",0.032357416,3
BP,GO:0043279,response to alkaloid,106/18493,0.003706028,0.016633808,0.005968149,836/5468,"CASP3,PPARG",0.040465658,2
BP,GO:0046928,regulation of neurotransmitter secretion,106/18493,0.003706028,0.016633808,0.005968149,2932/23621,"GSK3B,BACE1",0.029294379,2
BP,GO:0071887,leukocyte apoptotic process,107/18493,0.003774717,0.016898216,0.006063017,836/581,"CASP3,BAX",0.035649558,2
BP,GO:1901990,regulation of mitotic cell cycle phase transition,375/18493,0.003806468,0.016996324,0.006098218,351/596/581,"APP,BCL2,BAX",0.037706346,3
BP,GO:0001503,ossification,380/18493,0.003950727,0.017594989,0.006313017,596/43/5743,"BCL2,ACHE,PTGS2",0.039946022,3
BP,GO:0045765,regulation of angiogenesis,381/18493,0.003979977,0.01767969,0.006343407,4846/5743/5468,"NOS3,PTGS2,PPARG",0.049303112,3
BP,GO:0002244,hematopoietic progenitor cell differentiation,111/18493,0.004055417,0.017831453,0.006397859,1636/596,"ACE,BCL2",0.02115963,2
BP,GO:0021987,cerebral cortex development,111/18493,0.004055417,0.017831453,0.006397859,2932/581,"GSK3B,BAX",0.023521035,2
BP,GO:0099565,"chemical synaptic transmission, postsynaptic",111/18493,0.004055417,0.017831453,0.006397859,351/2932,"APP,GSK3B",0.034835531,2
BP,GO:1903828,negative regulation of cellular protein localization,111/18493,0.004055417,0.017831453,0.006397859,4137/2932,"MAPT,GSK3B",0.028334089,2
BP,GO:0007613,memory,112/18493,0.004127073,0.017963685,0.006445303,4137/5743,"MAPT,PTGS2",0.033796636,2
BP,GO:0014013,regulation of gliogenesis,112/18493,0.004127073,0.017963685,0.006445303,351/5468,"APP,PPARG",0.034356703,2
BP,GO:0046717,acid secretion,112/18493,0.004127073,0.017963685,0.006445303,1636/4843,"ACE,NOS2",0.025335317,2
BP,GO:0046822,regulation of nucleocytoplasmic transport,112/18493,0.004127073,0.017963685,0.006445303,2932/5743,"GSK3B,PTGS2",0.033997802,2
BP,GO:0042303,molting cycle,113/18493,0.00419932,0.018186528,0.006525259,596/5743,"BCL2,PTGS2",0.027100668,2
BP,GO:0042633,hair cycle,113/18493,0.00419932,0.018186528,0.006525259,596/5743,"BCL2,PTGS2",0.027100668,2
BP,GO:0098693,regulation of synaptic vesicle cycle,114/18493,0.004272156,0.018409689,0.006605328,2932/23621,"GSK3B,BACE1",0.028568942,2
BP,GO:2000134,negative regulation of G1/S transition of mitotic cell cycle,114/18493,0.004272156,0.018409689,0.006605328,596/581,"BCL2,BAX",0.01656245,2
BP,GO:0010876,lipid localization,393/18493,0.004341426,0.018661652,0.006695732,1636/4843/5468,"ACE,NOS2,PPARG",0.03879064,3
BP,GO:0048675,axon extension,116/18493,0.004419593,0.018950511,0.006799373,4137/2932,"MAPT,GSK3B",0.027905805,2
BP,GO:0009063,cellular amino acid catabolic process,118/18493,0.004569376,0.019544263,0.007012409,4846/4843,"NOS3,NOS2",0.026597918,2
BP,GO:0043062,extracellular structure organization,402/18493,0.004625307,0.019686035,0.007063277,351/102/4353,"APP,ADAM10,MPO",0.043658909,3
BP,GO:0051222,positive regulation of protein transport,402/18493,0.004625307,0.019686035,0.007063277,2932/43/5743,"GSK3B,ACHE,PTGS2",0.045494267,3
BP,GO:0022612,gland morphogenesis,120/18493,0.004721499,0.020000745,0.007176193,596/581,"BCL2,BAX",0.016218784,2
BP,GO:0030099,myeloid cell differentiation,405/18493,0.004722398,0.020000745,0.007176193,351/836/5468,"APP,CASP3,PPARG",0.058626048,3
BP,GO:0002687,positive regulation of leukocyte migration,121/18493,0.004798436,0.020174445,0.007238516,351/102,"APP,ADAM10",0.031073065,2
BP,GO:1900180,regulation of protein localization to nucleus,121/18493,0.004798436,0.020174445,0.007238516,2932/5743,"GSK3B,PTGS2",0.033016079,2
BP,GO:1902807,negative regulation of cell cycle G1/S phase transition,121/18493,0.004798436,0.020174445,0.007238516,596/581,"BCL2,BAX",0.016182933,2
BP,GO:0010595,positive regulation of endothelial cell migration,122/18493,0.004875954,0.020401087,0.007319834,4846/5743,"NOS3,PTGS2",0.034164834,2
BP,GO:0050853,B cell receptor signaling pathway,122/18493,0.004875954,0.020401087,0.007319834,596/581,"BCL2,BAX",0.016136618,2
BP,GO:1901987,regulation of cell cycle phase transition,412/18493,0.004953776,0.020627963,0.007401237,351/596/581,"APP,BCL2,BAX",0.035914374,3
BP,GO:0016079,synaptic vesicle exocytosis,123/18493,0.004954054,0.020627963,0.007401237,2932/23621,"GSK3B,BACE1",0.027755325,2
BP,GO:0010565,regulation of cellular ketone metabolic process,125/18493,0.005111992,0.021132829,0.007582381,5743/5468,"PTGS2,PPARG",0.032225374,2
BP,GO:0030183,B cell differentiation,125/18493,0.005111992,0.021132829,0.007582381,596/581,"BCL2,BAX",0.015990517,2
BP,GO:0071482,cellular response to light stimulus,125/18493,0.005111992,0.021132829,0.007582381,581/5743,"BAX,PTGS2",0.027820459,2
BP,GO:1901342,regulation of vasculature development,421/18493,0.005261285,0.021691518,0.007782836,4846/5743/5468,"NOS3,PTGS2,PPARG",0.046804506,3
BP,GO:0032355,response to estradiol,127/18493,0.005272244,0.021691518,0.007782836,836/5743,"CASP3,PTGS2",0.04349433,2
BP,GO:0032386,regulation of intracellular transport,422/18493,0.005296154,0.021738132,0.007799561,2932/23621/5743,"GSK3B,BACE1,PTGS2",0.046199208,3
BP,GO:0045598,regulation of fat cell differentiation,128/18493,0.005353235,0.021920355,0.007864942,5743/5468,"PTGS2,PPARG",0.031919675,2
BP,GO:0060249,anatomical structure homeostasis,425/18493,0.005401605,0.022066132,0.007917247,4846/596/581,"NOS3,BCL2,BAX",0.030542356,3
BP,GO:0050729,positive regulation of inflammatory response,133/18493,0.005766804,0.023502445,0.00843259,351/5743,"APP,PTGS2",0.037592468,2
BP,GO:0061041,regulation of wound healing,134/18493,0.005851234,0.023790428,0.008535917,5328/4846,"PLAU,NOS3",0.020418167,2
BP,GO:0008584,male gonad development,135/18493,0.005936234,0.02407937,0.008639589,596/581,"BCL2,BAX",0.015449359,2
BP,GO:0046546,development of primary male sexual characteristics,136/18493,0.006021803,0.024312325,0.008723172,596/581,"BCL2,BAX",0.015409443,2
BP,GO:0048813,dendrite morphogenesis,136/18493,0.006021803,0.024312325,0.008723172,2932/102,"GSK3B,ADAM10",0.023772992,2
BP,GO:0046683,response to organophosphorus,137/18493,0.00610794,0.02460261,0.008827326,351/5743,"APP,PTGS2",0.037133939,2
BP,GO:0045834,positive regulation of lipid metabolic process,138/18493,0.006194644,0.024893825,0.008931812,5743/5468,"PTGS2,PPARG",0.03085686,2
BP,GO:0006874,cellular calcium ion homeostasis,448/18493,0.006252664,0.025010656,0.008973731,351/596/581,"APP,BCL2,BAX",0.03413162,3
BP,GO:0042326,negative regulation of phosphorylation,448/18493,0.006252664,0.025010656,0.008973731,4137/836/581,"MAPT,CASP3,BAX",0.045108447,3
BP,GO:0050773,regulation of dendrite development,139/18493,0.006281915,0.025011863,0.008974164,2932/102,"GSK3B,ADAM10",0.023591554,2
BP,GO:0060078,regulation of postsynaptic membrane potential,139/18493,0.006281915,0.025011863,0.008974164,351/2932,"APP,GSK3B",0.031908172,2
BP,GO:0042110,T cell activation,451/18493,0.006369289,0.02518748,0.009037175,836/596/581,"CASP3,BCL2,BAX",0.03896576,3
BP,GO:0043254,regulation of protein complex assembly,451/18493,0.006369289,0.02518748,0.009037175,4137/2932/581,"MAPT,GSK3B,BAX",0.034363399,3
BP,GO:0042737,drug catabolic process,140/18493,0.00636975,0.02518748,0.009037175,4353/43,"MPO,ACHE",0.023114347,2
BP,GO:0023061,signal release,453/18493,0.006447767,0.025248155,0.009058945,2932/23621/4843,"GSK3B,BACE1,NOS2",0.036966395,3
BP,GO:0007612,learning,141/18493,0.006458151,0.025248155,0.009058945,351/5743,"APP,PTGS2",0.03687434,2
BP,GO:0042542,response to hydrogen peroxide,141/18493,0.006458151,0.025248155,0.009058945,836/596,"CASP3,BCL2",0.03048626,2
BP,GO:0051588,regulation of neurotransmitter transport,141/18493,0.006458151,0.025248155,0.009058945,2932/23621,"GSK3B,BACE1",0.026309989,2
BP,GO:0060041,retina development in camera-type eye,141/18493,0.006458151,0.025248155,0.009058945,43/581,"ACHE,BAX",0.019947522,2
BP,GO:0001667,ameboidal-type cell migration,456/18493,0.006566578,0.025614101,0.009190245,4846/5743/5468,"NOS3,PTGS2,PPARG",0.044773636,3
BP,GO:0015711,organic anion transport,460/18493,0.006727042,0.02618092,0.009393617,1636/4843/5468,"ACE,NOS2,PPARG",0.035491964,3
BP,GO:0055074,calcium ion homeostasis,461/18493,0.006767525,0.026279288,0.009428911,351/596/581,"APP,BCL2,BAX",0.033673758,3
BP,GO:0048592,eye morphogenesis,145/18493,0.006817378,0.026413519,0.009477073,596/581,"BCL2,BAX",0.015065777,2
BP,GO:0002262,myeloid cell homeostasis,146/18493,0.006908587,0.02670702,0.00958238,836/581,"CASP3,BAX",0.031650717,2
BP,GO:0006914,autophagy,466/18493,0.006972149,0.026821757,0.009623547,4137/836/596,"MAPT,CASP3,BCL2",0.042625444,3
BP,GO:0061919,process utilizing autophagic mechanism,466/18493,0.006972149,0.026821757,0.009623547,4137/836/596,"MAPT,CASP3,BCL2",0.042625444,3
BP,GO:0035264,multicellular organism growth,147/18493,0.007000355,0.026821757,0.009623547,351/596,"APP,BCL2",0.025169584,2
BP,GO:0043524,negative regulation of neuron apoptotic process,147/18493,0.007000355,0.026821757,0.009623547,596/581,"BCL2,BAX",0.015002189,2
BP,GO:1903305,regulation of regulated secretory pathway,148/18493,0.00709268,0.027115379,0.009728898,2932/23621,"GSK3B,BACE1",0.025799752,2
BP,GO:0001890,placenta development,149/18493,0.007185563,0.027169919,0.009748466,5743/5468,"PTGS2,PPARG",0.030125859,2
BP,GO:0002673,regulation of acute inflammatory response,149/18493,0.007185563,0.027169919,0.009748466,5743/5468,"PTGS2,PPARG",0.030125859,2
BP,GO:0010970,transport along microtubule,149/18493,0.007185563,0.027169919,0.009748466,351/4137,"APP,MAPT",0.031011761,2
BP,GO:0060402,calcium ion transport into cytosol,149/18493,0.007185563,0.027169919,0.009748466,596/581,"BCL2,BAX",0.014948719,2
BP,GO:0099111,microtubule-based transport,149/18493,0.007185563,0.027169919,0.009748466,351/4137,"APP,MAPT",0.031011761,2
BP,GO:0031214,biomineral tissue development,150/18493,0.007279002,0.027463135,0.009853671,4846/5743,"NOS3,PTGS2",0.031555564,2
BP,GO:0022604,regulation of cell morphogenesis,474/18493,0.007307242,0.027509615,0.009870348,4137/2932/102,"MAPT,GSK3B,ADAM10",0.035534472,3
BP,GO:0010975,regulation of neuron projection development,478/18493,0.007478358,0.028092616,0.010079527,4137/2932/102,"MAPT,GSK3B,ADAM10",0.035327081,3
BP,GO:0017156,calcium ion regulated exocytosis,153/18493,0.007562648,0.028347625,0.010171023,2932/23621,"GSK3B,BACE1",0.025481928,2
BP,GO:0048489,synaptic vesicle transport,154/18493,0.007658303,0.028582175,0.010255178,2932/23621,"GSK3B,BACE1",0.025423001,2
BP,GO:0097480,establishment of synaptic vesicle localization,154/18493,0.007658303,0.028582175,0.010255178,2932/23621,"GSK3B,BACE1",0.025423001,2
BP,GO:0072503,cellular divalent inorganic cation homeostasis,483/18493,0.00769562,0.02865955,0.01028294,351/596/581,"APP,BCL2,BAX",0.032871415,3
BP,GO:0071695,anatomical structure maturation,155/18493,0.007754509,0.028816757,0.010339346,351/596,"APP,BCL2",0.024670555,2
BP,GO:0043312,neutrophil degranulation,485/18493,0.007783575,0.028862698,0.010355829,5328/102/4353,"PLAU,ADAM10,MPO",0.026966608,3
BP,GO:2001236,regulation of extrinsic apoptotic signaling pathway,156/18493,0.007851267,0.029051367,0.010423523,4846/596,"NOS3,BCL2",0.020208221,2
BP,GO:0002283,neutrophil activation involved in immune response,488/18493,0.007916636,0.029230657,0.010487852,5328/102/4353,"PLAU,ADAM10,MPO",0.026870248,3
BP,GO:0046661,male sex differentiation,157/18493,0.007948574,0.029286003,0.01050771,596/581,"BCL2,BAX",0.014637778,2
BP,GO:0090316,positive regulation of intracellular protein transport,158/18493,0.00804643,0.029537631,0.010597993,2932/5743,"GSK3B,PTGS2",0.02979132,2
BP,GO:0051656,establishment of organelle localization,491/18493,0.008051056,0.029537631,0.010597993,4137/2932/23621,"MAPT,GSK3B,BACE1",0.037491118,3
BP,GO:0050806,positive regulation of synaptic transmission,159/18493,0.008144834,0.029818377,0.010698723,351/5743,"APP,PTGS2",0.035206809,2
BP,GO:0051051,negative regulation of transport,495/18493,0.0082324,0.029851822,0.010710723,4846/596/5743,"NOS3,BCL2,PTGS2",0.037312773,3
BP,GO:0071456,cellular response to hypoxia,160/18493,0.008243786,0.029851822,0.010710723,596/5743,"BCL2,PTGS2",0.023749061,2
BP,GO:1903034,regulation of response to wounding,160/18493,0.008243786,0.029851822,0.010710723,5328/4846,"PLAU,NOS3",0.019178581,2
BP,GO:0050954,sensory perception of mechanical stimulus,161/18493,0.008343284,0.029851822,0.010710723,836/23621,"CASP3,BACE1",0.035279158,2
BP,GO:0060401,cytosolic calcium ion transport,161/18493,0.008343284,0.029851822,0.010710723,596/581,"BCL2,BAX",0.014558441,2
BP,GO:1990138,neuron projection extension,161/18493,0.008343284,0.029851822,0.010710723,4137/2932,"MAPT,GSK3B",0.024708362,2
BP,GO:0042119,neutrophil activation,498/18493,0.008370002,0.029851822,0.010710723,5328/102/4353,"PLAU,ADAM10,MPO",0.0267103,3
BP,GO:0060627,regulation of vesicle-mediated transport,498/18493,0.008370002,0.029851822,0.010710723,2932/23621/5468,"GSK3B,BACE1,PPARG",0.037191752,3
BP,GO:0001660,fever generation,10/18493,0.008620405,0.029851822,0.010710723,5743,PTGS2,0.017259769,1
BP,GO:0002679,respiratory burst involved in defense response,10/18493,0.008620405,0.029851822,0.010710723,4353,MPO,0.01107738,1
BP,GO:0007220,Notch receptor processing,10/18493,0.008620405,0.029851822,0.010710723,102,ADAM10,0.010018051,1
BP,GO:0014041,regulation of neuron maturation,10/18493,0.008620405,0.029851822,0.010710723,596,BCL2,0.006489292,1
BP,GO:0021548,pons development,10/18493,0.008620405,0.029851822,0.010710723,596,BCL2,0.006489292,1
BP,GO:0032025,response to cobalt ion,10/18493,0.008620405,0.029851822,0.010710723,836,CASP3,0.02260903,1
BP,GO:0043653,mitochondrial fragmentation involved in apoptotic process,10/18493,0.008620405,0.029851822,0.010710723,581,BAX,0.008069149,1
BP,GO:0045713,low-density lipoprotein particle receptor biosynthetic process,10/18493,0.008620405,0.029851822,0.010710723,5468,PPARG,0.01207957,1
BP,GO:0051124,synaptic growth at neuromuscular junction,10/18493,0.008620405,0.029851822,0.010710723,351,APP,0.017935804,1
BP,GO:0060068,vagina development,10/18493,0.008620405,0.029851822,0.010710723,581,BAX,0.008069149,1
BP,GO:0071838,cell proliferation in bone marrow,10/18493,0.008620405,0.029851822,0.010710723,1636,ACE,0.011962679,1
BP,GO:0090336,positive regulation of brown fat cell differentiation,10/18493,0.008620405,0.029851822,0.010710723,5743,PTGS2,0.017259769,1
BP,GO:1900272,negative regulation of long-term synaptic potentiation,10/18493,0.008620405,0.029851822,0.010710723,351,APP,0.017935804,1
BP,GO:1902004,positive regulation of amyloid-beta formation,10/18493,0.008620405,0.029851822,0.010710723,351,APP,0.017935804,1
BP,GO:1902510,regulation of apoptotic DNA fragmentation,10/18493,0.008620405,0.029851822,0.010710723,581,BAX,0.008069149,1
BP,GO:1904338,regulation of dopaminergic neuron differentiation,10/18493,0.008620405,0.029851822,0.010710723,2932,GSK3B,0.012442054,1
BP,GO:1904779,regulation of protein localization to centrosome,10/18493,0.008620405,0.029851822,0.010710723,2932,GSK3B,0.012442054,1
BP,GO:1990535,neuron projection maintenance,10/18493,0.008620405,0.029851822,0.010710723,351,APP,0.017935804,1
BP,GO:2001269,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,10/18493,0.008620405,0.029851822,0.010710723,581,BAX,0.008069149,1
BP,GO:0007416,synapse assembly,165/18493,0.00874672,0.030108233,0.010802722,351/43,"APP,ACHE",0.028835628,2
BP,GO:0010634,positive regulation of epithelial cell migration,165/18493,0.00874672,0.030108233,0.010802722,4846/5743,"NOS3,PTGS2",0.030748406,2
BP,GO:0097479,synaptic vesicle localization,165/18493,0.00874672,0.030108233,0.010802722,2932/23621,"GSK3B,BACE1",0.025051018,2
BP,GO:2000045,regulation of G1/S transition of mitotic cell cycle,166/18493,0.008848936,0.030399527,0.010907238,596/581,"BCL2,BAX",0.014483063,2
BP,GO:0007269,neurotransmitter secretion,167/18493,0.008951693,0.030630744,0.010990198,2932/23621,"GSK3B,BACE1",0.024927974,2
BP,GO:0099643,signal release from synapse,167/18493,0.008951693,0.030630744,0.010990198,2932/23621,"GSK3B,BACE1",0.024927974,2
BP,GO:0030705,cytoskeleton-dependent intracellular transport,168/18493,0.00905499,0.030861978,0.011073163,351/4137,"APP,MAPT",0.029915882,2
BP,GO:0048660,regulation of smooth muscle cell proliferation,168/18493,0.00905499,0.030861978,0.011073163,5743/5468,"PTGS2,PPARG",0.029061286,2
BP,GO:0036294,cellular response to decreased oxygen levels,170/18493,0.0092632,0.031257682,0.01121514,596/5743,"BCL2,PTGS2",0.023437823,2
BP,GO:0048659,smooth muscle cell proliferation,170/18493,0.0092632,0.031257682,0.01121514,5743/5468,"PTGS2,PPARG",0.028954839,2
BP,GO:0001659,temperature homeostasis,171/18493,0.009368112,0.031257682,0.01121514,43/5743,"ACHE,PTGS2",0.027860036,2
BP,GO:0002003,angiotensin maturation,11/18493,0.009478603,0.031257682,0.01121514,1636,ACE,0.011805905,1
BP,GO:0016264,gap junction assembly,11/18493,0.009478603,0.031257682,0.01121514,1636,ACE,0.011805905,1
BP,GO:0016322,neuron remodeling,11/18493,0.009478603,0.031257682,0.01121514,351,APP,0.01770075,1
BP,GO:0019371,cyclooxygenase pathway,11/18493,0.009478603,0.031257682,0.01121514,5743,PTGS2,0.017033575,1
BP,GO:0019896,axonal transport of mitochondrion,11/18493,0.009478603,0.031257682,0.01121514,4137,MAPT,0.012105555,1
BP,GO:0031652,positive regulation of heat generation,11/18493,0.009478603,0.031257682,0.01121514,5743,PTGS2,0.017033575,1
BP,GO:0033197,response to vitamin E,11/18493,0.009478603,0.031257682,0.01121514,5468,PPARG,0.011921264,1
BP,GO:0046007,negative regulation of activated T cell proliferation,11/18493,0.009478603,0.031257682,0.01121514,836,CASP3,0.022312733,1
BP,GO:0048742,regulation of skeletal muscle fiber development,11/18493,0.009478603,0.031257682,0.01121514,596,BCL2,0.006404248,1
BP,GO:0051974,negative regulation of telomerase activity,11/18493,0.009478603,0.031257682,0.01121514,5468,PPARG,0.011921264,1
BP,GO:0060100,"positive regulation of phagocytosis, engulfment",11/18493,0.009478603,0.031257682,0.01121514,5468,PPARG,0.011921264,1
BP,GO:0090042,tubulin deacetylation,11/18493,0.009478603,0.031257682,0.01121514,4137,MAPT,0.012105555,1
BP,GO:1902337,regulation of apoptotic process involved in morphogenesis,11/18493,0.009478603,0.031257682,0.01121514,581,BAX,0.0079634,1
BP,GO:1905155,positive regulation of membrane invagination,11/18493,0.009478603,0.031257682,0.01121514,5468,PPARG,0.011921264,1
BP,GO:0008361,regulation of cell size,175/18493,0.009793115,0.032172058,0.011543215,4137/2932,"MAPT,GSK3B",0.024181671,2
BP,GO:0070507,regulation of microtubule cytoskeleton organization,175/18493,0.009793115,0.032172058,0.011543215,4137/2932,"MAPT,GSK3B",0.024181671,2
BP,GO:1905475,regulation of protein localization to membrane,177/18493,0.010008818,0.032818286,0.01177508,596/102,"BCL2,ADAM10",0.016061977,2
BP,GO:0042098,T cell proliferation,178/18493,0.010117466,0.032954278,0.011823873,836/581,"CASP3,BAX",0.029814359,2
BP,GO:0071346,cellular response to interferon-gamma,178/18493,0.010117466,0.032954278,0.011823873,4843/5468,"NOS2,PPARG",0.021624298,2
BP,GO:0002002,regulation of angiotensin levels in blood,12/18493,0.010336104,0.032954278,0.011823873,1636,ACE,0.011625841,1
BP,GO:0002674,negative regulation of acute inflammatory response,12/18493,0.010336104,0.032954278,0.011823873,5468,PPARG,0.01173944,1
BP,GO:0006983,ER overload response,12/18493,0.010336104,0.032954278,0.011823873,2932,GSK3B,0.012091717,1
BP,GO:0009886,post-embryonic animal morphogenesis,12/18493,0.010336104,0.032954278,0.011823873,581,BAX,0.007841942,1
BP,GO:0010889,regulation of sequestering of triglyceride,12/18493,0.010336104,0.032954278,0.011823873,5468,PPARG,0.01173944,1
BP,GO:0050966,detection of mechanical stimulus involved in sensory perception of pain,12/18493,0.010336104,0.032954278,0.011823873,23621,BACE1,0.01231337,1
BP,GO:0051712,positive regulation of killing of cells of other organism,12/18493,0.010336104,0.032954278,0.011823873,4843,NOS2,0.009884858,1
BP,GO:1903624,regulation of DNA catabolic process,12/18493,0.010336104,0.032954278,0.011823873,581,BAX,0.007841942,1
BP,GO:1903894,regulation of IRE1-mediated unfolded protein response,12/18493,0.010336104,0.032954278,0.011823873,581,BAX,0.007841942,1
BP,GO:1905461,positive regulation of vascular associated smooth muscle cell apoptotic process,12/18493,0.010336104,0.032954278,0.011823873,5468,PPARG,0.01173944,1
BP,GO:0002685,regulation of leukocyte migration,180/18493,0.010336353,0.032954278,0.011823873,351/102,"APP,ADAM10",0.027166745,2
BP,GO:0048639,positive regulation of developmental growth,180/18493,0.010336353,0.032954278,0.011823873,4137/596,"MAPT,BCL2",0.01822749,2
BP,GO:0050770,regulation of axonogenesis,180/18493,0.010336353,0.032954278,0.011823873,4137/2932,"MAPT,GSK3B",0.024012637,2
BP,GO:0042594,response to starvation,183/18493,0.010668646,0.033888641,0.012159119,596/5468,"BCL2,PPARG",0.017898164,2
BP,GO:0050864,regulation of B cell activation,183/18493,0.010668646,0.033888641,0.012159119,836/596,"CASP3,BCL2",0.028047305,2
BP,GO:0030308,negative regulation of cell growth,184/18493,0.010780464,0.034056016,0.012219173,596/5468,"BCL2,PPARG",0.01787211,2
BP,GO:0043112,receptor metabolic process,184/18493,0.010780464,0.034056016,0.012219173,43/5468,"ACHE,PPARG",0.022184911,2
BP,GO:0050866,negative regulation of cell activation,184/18493,0.010780464,0.034056016,0.012219173,836/4846,"CASP3,NOS3",0.034815447,2
BP,GO:1902806,regulation of cell cycle G1/S phase transition,185/18493,0.010892806,0.034171992,0.012260784,596/581,"BCL2,BAX",0.013998076,2
BP,GO:0006367,transcription initiation from RNA polymerase II promoter,186/18493,0.011005672,0.034171992,0.012260784,581/5468,"BAX,PPARG",0.01937318,2
BP,GO:0071478,cellular response to radiation,186/18493,0.011005672,0.034171992,0.012260784,581/5743,"BAX,PTGS2",0.02435399,2
BP,GO:0001967,suckling behavior,13/18493,0.01119291,0.034171992,0.012260784,351,APP,0.017245442,1
BP,GO:0003084,positive regulation of systemic arterial blood pressure,13/18493,0.01119291,0.034171992,0.012260784,1636,ACE,0.011502227,1
BP,GO:0010745,negative regulation of macrophage derived foam cell differentiation,13/18493,0.01119291,0.034171992,0.012260784,5468,PPARG,0.011614619,1
BP,GO:0014745,negative regulation of muscle adaptation,13/18493,0.01119291,0.034171992,0.012260784,4846,NOS3,0.013041635,1
BP,GO:0030011,maintenance of cell polarity,13/18493,0.01119291,0.034171992,0.012260784,2932,GSK3B,0.011963151,1
BP,GO:0031650,regulation of heat generation,13/18493,0.01119291,0.034171992,0.012260784,5743,PTGS2,0.016595428,1
BP,GO:0032310,prostaglandin secretion,13/18493,0.01119291,0.034171992,0.012260784,4843,NOS2,0.009779756,1
BP,GO:0044130,negative regulation of growth of symbiont in host,13/18493,0.01119291,0.034171992,0.012260784,4353,MPO,0.010651004,1
BP,GO:0050872,white fat cell differentiation,13/18493,0.01119291,0.034171992,0.012260784,5468,PPARG,0.011614619,1
BP,GO:0060099,"regulation of phagocytosis, engulfment",13/18493,0.01119291,0.034171992,0.012260784,5468,PPARG,0.011614619,1
BP,GO:0060965,negative regulation of gene silencing by miRNA,13/18493,0.01119291,0.034171992,0.012260784,5468,PPARG,0.011614619,1
BP,GO:1900103,positive regulation of endoplasmic reticulum unfolded protein response,13/18493,0.01119291,0.034171992,0.012260784,581,BAX,0.007758562,1
BP,GO:1900119,positive regulation of execution phase of apoptosis,13/18493,0.01119291,0.034171992,0.012260784,581,BAX,0.007758562,1
BP,GO:1900452,regulation of long-term synaptic depression,13/18493,0.01119291,0.034171992,0.012260784,4137,MAPT,0.011794169,1
BP,GO:1902993,positive regulation of amyloid precursor protein catabolic process,13/18493,0.01119291,0.034171992,0.012260784,351,APP,0.017245442,1
BP,GO:1904748,regulation of apoptotic process involved in development,13/18493,0.01119291,0.034171992,0.012260784,581,BAX,0.007758562,1
BP,GO:0031099,regeneration,188/18493,0.011232975,0.034233827,0.01228297,596/5468,"BCL2,PPARG",0.017844573,2
BP,GO:0007219,Notch signaling pathway,189/18493,0.011347408,0.034521693,0.012386256,351/102,"APP,ADAM10",0.026796839,2
BP,GO:0042180,cellular ketone metabolic process,190/18493,0.011462363,0.034810129,0.012489745,5743/5468,"PTGS2,PPARG",0.028055459,2
BP,GO:0007565,female pregnancy,191/18493,0.011577837,0.035037658,0.012571382,596/5743,"BCL2,PTGS2",0.022665747,2
BP,GO:1901991,negative regulation of mitotic cell cycle phase transition,191/18493,0.011577837,0.035037658,0.012571382,596/581,"BCL2,BAX",0.013894357,2
BP,GO:0099504,synaptic vesicle cycle,195/18493,0.012044916,0.03559095,0.012769901,2932/23621,"GSK3B,BACE1",0.023854642,2
BP,GO:0006878,cellular copper ion homeostasis,14/18493,0.01204902,0.03559095,0.012769901,351,APP,0.017037634,1
BP,GO:0010248,establishment or maintenance of transmembrane electrochemical gradient,14/18493,0.01204902,0.03559095,0.012769901,581,BAX,0.007665071,1
BP,GO:0019372,lipoxygenase pathway,14/18493,0.01204902,0.03559095,0.012769901,5743,PTGS2,0.016395453,1
BP,GO:0034349,glial cell apoptotic process,14/18493,0.01204902,0.03559095,0.012769901,836,CASP3,0.02147684,1
BP,GO:0034374,low-density lipoprotein particle remodeling,14/18493,0.01204902,0.03559095,0.012769901,4353,MPO,0.010522659,1
BP,GO:0036295,cellular response to increased oxygen levels,14/18493,0.01204902,0.03559095,0.012769901,5468,PPARG,0.011474662,1
BP,GO:0043374,"CD8-positive, alpha-beta T cell differentiation",14/18493,0.01204902,0.03559095,0.012769901,596,BCL2,0.006164328,1
BP,GO:0044126,regulation of growth of symbiont in host,14/18493,0.01204902,0.03559095,0.012769901,4353,MPO,0.010522659,1
BP,GO:0044146,negative regulation of growth of symbiont involved in interaction with host,14/18493,0.01204902,0.03559095,0.012769901,4353,MPO,0.010522659,1
BP,GO:0048711,positive regulation of astrocyte differentiation,14/18493,0.01204902,0.03559095,0.012769901,351,APP,0.017037634,1
BP,GO:0051709,regulation of killing of cells of other organism,14/18493,0.01204902,0.03559095,0.012769901,4843,NOS2,0.00966191,1
BP,GO:0150078,positive regulation of neuroinflammatory response,14/18493,0.01204902,0.03559095,0.012769901,351,APP,0.017037634,1
BP,GO:1905153,regulation of membrane invagination,14/18493,0.01204902,0.03559095,0.012769901,5468,PPARG,0.011474662,1
BP,GO:0009746,response to hexose,196/18493,0.012162976,0.035866251,0.012868678,836/5743,"CASP3,PTGS2",0.037784808,2
BP,GO:0002573,myeloid leukocyte differentiation,197/18493,0.012281552,0.03615421,0.012971997,351/5468,"APP,PPARG",0.028378081,2
BP,GO:0034341,response to interferon-gamma,198/18493,0.012400641,0.036442699,0.013075505,4843/5468,"NOS2,PPARG",0.020986715,2
BP,GO:0006473,protein acetylation,199/18493,0.012520242,0.036615539,0.01313752,4137/2932,"MAPT,GSK3B",0.023271342,2
BP,GO:0071222,cellular response to lipopolysaccharide,199/18493,0.012520242,0.036615539,0.01313752,4846/4843,"NOS3,NOS2",0.022354558,2
BP,GO:0045766,positive regulation of angiogenesis,200/18493,0.012640356,0.036615539,0.01313752,4846/5743,"NOS3,PTGS2",0.029030809,2
BP,GO:1902905,positive regulation of supramolecular fiber organization,200/18493,0.012640356,0.036615539,0.01313752,351/4137,"APP,MAPT",0.028445579,2
BP,GO:0034284,response to monosaccharide,201/18493,0.012760981,0.036615539,0.01313752,836/5743,"CASP3,PTGS2",0.037550059,2
BP,GO:0010820,positive regulation of T cell chemotaxis,15/18493,0.012904435,0.036615539,0.01313752,102,ADAM10,0.009435408,1
BP,GO:0010885,regulation of cholesterol storage,15/18493,0.012904435,0.036615539,0.01313752,5468,PPARG,0.011377031,1
BP,GO:0015732,prostaglandin transport,15/18493,0.012904435,0.036615539,0.01313752,4843,NOS2,0.009579702,1
BP,GO:0030730,sequestering of triglyceride,15/18493,0.012904435,0.036615539,0.01313752,5468,PPARG,0.011377031,1
BP,GO:0030889,negative regulation of B cell proliferation,15/18493,0.012904435,0.036615539,0.01313752,836,CASP3,0.021294105,1
BP,GO:0033689,negative regulation of osteoblast proliferation,15/18493,0.012904435,0.036615539,0.01313752,596,BCL2,0.006111879,1
BP,GO:0034356,NAD biosynthesis via nicotinamide riboside salvage pathway,15/18493,0.012904435,0.036615539,0.01313752,5743,PTGS2,0.016255954,1
BP,GO:0044144,modulation of growth of symbiont involved in interaction with host,15/18493,0.012904435,0.036615539,0.01313752,4353,MPO,0.010433128,1
BP,GO:0046321,positive regulation of fatty acid oxidation,15/18493,0.012904435,0.036615539,0.01313752,5468,PPARG,0.011377031,1
BP,GO:0048569,post-embryonic animal organ development,15/18493,0.012904435,0.036615539,0.01313752,581,BAX,0.007599853,1
BP,GO:0060134,prepulse inhibition,15/18493,0.012904435,0.036615539,0.01313752,23621,BACE1,0.011933243,1
BP,GO:0060149,negative regulation of posttranscriptional gene silencing,15/18493,0.012904435,0.036615539,0.01313752,5468,PPARG,0.011377031,1
BP,GO:0060967,negative regulation of gene silencing by RNA,15/18493,0.012904435,0.036615539,0.01313752,5468,PPARG,0.011377031,1
BP,GO:0099633,protein localization to postsynaptic specialization membrane,15/18493,0.012904435,0.036615539,0.01313752,102,ADAM10,0.009435408,1
BP,GO:0099645,neurotransmitter receptor localization to postsynaptic specialization membrane,15/18493,0.012904435,0.036615539,0.01313752,102,ADAM10,0.009435408,1
BP,GO:1902683,regulation of receptor localization to synapse,15/18493,0.012904435,0.036615539,0.01313752,102,ADAM10,0.009435408,1
BP,GO:0043903,"regulation of symbiosis, encompassing mutualism through parasitism",203/18493,0.013003762,0.036836886,0.013216938,596/4353,"BCL2,MPO",0.016514857,2
BP,GO:0017157,regulation of exocytosis,204/18493,0.013125916,0.037061409,0.013297496,2932/23621,"GSK3B,BACE1",0.023565119,2
BP,GO:0032886,regulation of microtubule-based process,204/18493,0.013125916,0.037061409,0.013297496,4137/2932,"MAPT,GSK3B",0.023186177,2
BP,GO:0050670,regulation of lymphocyte proliferation,205/18493,0.013248577,0.037285897,0.013378042,836/596,"CASP3,BCL2",0.027255646,2
BP,GO:0099003,vesicle-mediated transport in synapse,205/18493,0.013248577,0.037285897,0.013378042,2932/23621,"GSK3B,BACE1",0.023521932,2
BP,GO:0032944,regulation of mononuclear cell proliferation,206/18493,0.013371745,0.037449555,0.013436762,836/596,"CASP3,BCL2",0.027219354,2
BP,GO:0071219,cellular response to molecule of bacterial origin,206/18493,0.013371745,0.037449555,0.013436762,4846/4843,"NOS3,NOS2",0.022202327,2
BP,GO:2001020,regulation of response to DNA damage stimulus,206/18493,0.013371745,0.037449555,0.013436762,4137/596,"MAPT,BCL2",0.017544493,2
BP,GO:2000027,regulation of animal organ morphogenesis,208/18493,0.013619599,0.037619969,0.013497906,596/581,"BCL2,BAX",0.013599534,2
BP,GO:0003184,pulmonary valve morphogenesis,16/18493,0.013759155,0.037619969,0.013497906,4846,NOS3,0.012670324,1
BP,GO:0010819,regulation of T cell chemotaxis,16/18493,0.013759155,0.037619969,0.013497906,102,ADAM10,0.009358202,1
BP,GO:0031000,response to caffeine,16/18493,0.013759155,0.037619969,0.013497906,5468,PPARG,0.011283937,1
BP,GO:0032225,"regulation of synaptic transmission, dopaminergic",16/18493,0.013759155,0.037619969,0.013497906,5743,PTGS2,0.016122937,1
BP,GO:0032930,positive regulation of superoxide anion generation,16/18493,0.013759155,0.037619969,0.013497906,4137,MAPT,0.011458375,1
BP,GO:0033033,negative regulation of myeloid cell apoptotic process,16/18493,0.013759155,0.037619969,0.013497906,596,BCL2,0.006061868,1
BP,GO:0036270,response to diuretic,16/18493,0.013759155,0.037619969,0.013497906,5468,PPARG,0.011283937,1
BP,GO:0045986,negative regulation of smooth muscle contraction,16/18493,0.013759155,0.037619969,0.013497906,5743,PTGS2,0.016122937,1
BP,GO:0070885,negative regulation of calcineurin-NFAT signaling cascade,16/18493,0.013759155,0.037619969,0.013497906,2932,GSK3B,0.011622546,1
BP,GO:0071380,cellular response to prostaglandin E stimulus,16/18493,0.013759155,0.037619969,0.013497906,5468,PPARG,0.011283937,1
BP,GO:0090335,regulation of brown fat cell differentiation,16/18493,0.013759155,0.037619969,0.013497906,5743,PTGS2,0.016122937,1
BP,GO:0106057,negative regulation of calcineurin-mediated signaling,16/18493,0.013759155,0.037619969,0.013497906,2932,GSK3B,0.011622546,1
BP,GO:1902166,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,16/18493,0.013759155,0.037619969,0.013497906,596,BCL2,0.006061868,1
BP,GO:2001267,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,16/18493,0.013759155,0.037619969,0.013497906,581,BAX,0.007537666,1
BP,GO:0048762,mesenchymal cell differentiation,210/18493,0.013869471,0.037861683,0.013584631,2932/596,"GSK3B,BCL2",0.017649885,2
BP,GO:0002526,acute inflammatory response,211/18493,0.013995161,0.038084469,0.013664566,5743/5468,"PTGS2,PPARG",0.027304343,2
BP,GO:1901988,negative regulation of cell cycle phase transition,211/18493,0.013995161,0.038084469,0.013664566,596/581,"BCL2,BAX",0.013548657,2
BP,GO:0008037,cell recognition,213/18493,0.014248045,0.038711671,0.013889604,351/836,"APP,CASP3",0.037544013,2
BP,GO:0032388,positive regulation of intracellular transport,214/18493,0.014375238,0.038896274,0.013955839,2932/5743,"GSK3B,PTGS2",0.02746328,2
BP,GO:0050807,regulation of synapse organization,214/18493,0.014375238,0.038896274,0.013955839,351/102,"APP,ADAM10",0.025847051,2
BP,GO:0010878,cholesterol storage,17/18493,0.014613182,0.038896274,0.013955839,5468,PPARG,0.011169167,1
BP,GO:0031649,heat generation,17/18493,0.014613182,0.038896274,0.013955839,5743,PTGS2,0.015958949,1
BP,GO:0032966,negative regulation of collagen biosynthetic process,17/18493,0.014613182,0.038896274,0.013955839,5468,PPARG,0.011169167,1
BP,GO:0044117,growth of symbiont in host,17/18493,0.014613182,0.038896274,0.013955839,4353,MPO,0.010242509,1
BP,GO:0048311,mitochondrion distribution,17/18493,0.014613182,0.038896274,0.013955839,4137,MAPT,0.011341831,1
BP,GO:0048714,positive regulation of oligodendrocyte differentiation,17/18493,0.014613182,0.038896274,0.013955839,5468,PPARG,0.011169167,1
BP,GO:0055070,copper ion homeostasis,17/18493,0.014613182,0.038896274,0.013955839,351,APP,0.016584033,1
BP,GO:0060850,regulation of transcription involved in cell fate commitment,17/18493,0.014613182,0.038896274,0.013955839,5468,PPARG,0.011169167,1
BP,GO:1903978,regulation of microglial cell activation,17/18493,0.014613182,0.038896274,0.013955839,351,APP,0.016584033,1
BP,GO:2000811,negative regulation of anoikis,17/18493,0.014613182,0.038896274,0.013955839,596,BCL2,0.006000212,1
BP,GO:0007584,response to nutrient,216/18493,0.014631122,0.038896274,0.013955839,5743/5468,"PTGS2,PPARG",0.027128116,2
BP,GO:0070663,regulation of leukocyte proliferation,216/18493,0.014631122,0.038896274,0.013955839,836/596,"CASP3,BCL2",0.026905263,2
BP,GO:0045444,fat cell differentiation,217/18493,0.01475981,0.039118024,0.014035402,5743/5468,"PTGS2,PPARG",0.027080617,2
BP,GO:0045665,negative regulation of neuron differentiation,217/18493,0.01475981,0.039118024,0.014035402,351/2932,"APP,GSK3B",0.028039185,2
BP,GO:0042445,hormone metabolic process,218/18493,0.014888995,0.03933973,0.014114949,1636/43,"ACE,ACHE",0.021130483,2
BP,GO:0072331,signal transduction by p53 class mediator,218/18493,0.014888995,0.03933973,0.014114949,596/581,"BCL2,BAX",0.013414212,2
BP,GO:0019722,calcium-mediated signaling,220/18493,0.015148852,0.03977104,0.014269702,4137/2932,"MAPT,GSK3B",0.022689669,2
BP,GO:0050803,regulation of synapse structure or activity,220/18493,0.015148852,0.03977104,0.014269702,351/102,"APP,ADAM10",0.025670002,2
BP,GO:0044706,multi-multicellular organism process,221/18493,0.015279522,0.03977104,0.014269702,596/5743,"BCL2,PTGS2",0.021808744,2
BP,GO:0010224,response to UV-B,18/18493,0.015466516,0.03977104,0.014269702,596,BCL2,0.005959112,1
BP,GO:0010544,negative regulation of platelet activation,18/18493,0.015466516,0.03977104,0.014269702,4846,NOS3,0.012455545,1
BP,GO:0010713,negative regulation of collagen metabolic process,18/18493,0.015466516,0.03977104,0.014269702,5468,PPARG,0.011092659,1
BP,GO:0030540,female genitalia development,18/18493,0.015466516,0.03977104,0.014269702,581,BAX,0.007409893,1
BP,GO:0031293,membrane protein intracellular domain proteolysis,18/18493,0.015466516,0.03977104,0.014269702,102,ADAM10,0.009199568,1
BP,GO:0033189,response to vitamin A,18/18493,0.015466516,0.03977104,0.014269702,5468,PPARG,0.011092659,1
BP,GO:0033599,regulation of mammary gland epithelial cell proliferation,18/18493,0.015466516,0.03977104,0.014269702,581,BAX,0.007409893,1
BP,GO:0034063,stress granule assembly,18/18493,0.015466516,0.03977104,0.014269702,4137,MAPT,0.011264141,1
BP,GO:0044110,growth involved in symbiotic interaction,18/18493,0.015466516,0.03977104,0.014269702,4353,MPO,0.010172349,1
BP,GO:0044116,growth of symbiont involved in interaction with host,18/18493,0.015466516,0.03977104,0.014269702,4353,MPO,0.010172349,1
BP,GO:0070230,positive regulation of lymphocyte apoptotic process,18/18493,0.015466516,0.03977104,0.014269702,581,BAX,0.007409893,1
BP,GO:0070242,thymocyte apoptotic process,18/18493,0.015466516,0.03977104,0.014269702,581,BAX,0.007409893,1
BP,GO:0071318,cellular response to ATP,18/18493,0.015466516,0.03977104,0.014269702,5743,PTGS2,0.015849632,1
BP,GO:1900273,positive regulation of long-term synaptic potentiation,18/18493,0.015466516,0.03977104,0.014269702,351,APP,0.016470434,1
BP,GO:1902165,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,18/18493,0.015466516,0.03977104,0.014269702,596,BCL2,0.005959112,1
BP,GO:0009743,response to carbohydrate,223/18493,0.015542342,0.039847428,0.01429711,836/5743,"CASP3,PTGS2",0.0365897,2
BP,GO:1901605,alpha-amino acid metabolic process,223/18493,0.015542342,0.039847428,0.01429711,4846/4843,"NOS3,NOS2",0.021782831,2
BP,GO:0046777,protein autophosphorylation,227/18493,0.016073875,0.040987648,0.014706216,2932/1636,"GSK3B,ACE",0.022201434,2
BP,GO:1904018,positive regulation of vasculature development,228/18493,0.016207982,0.040987648,0.014706216,4846/5743,"NOS3,PTGS2",0.028040686,2
BP,GO:0001991,regulation of systemic arterial blood pressure by circulatory renin-angiotensin,19/18493,0.016319156,0.040987648,0.014706216,1636,ACE,0.010882669,1
BP,GO:0002076,osteoblast development,19/18493,0.016319156,0.040987648,0.014706216,43,ACHE,0.009979818,1
BP,GO:0002320,lymphoid progenitor cell differentiation,19/18493,0.016319156,0.040987648,0.014706216,596,BCL2,0.005903428,1
BP,GO:0002363,alpha-beta T cell lineage commitment,19/18493,0.016319156,0.040987648,0.014706216,596,BCL2,0.005903428,1
BP,GO:0002902,regulation of B cell apoptotic process,19/18493,0.016319156,0.040987648,0.014706216,581,BAX,0.007340653,1
BP,GO:0003177,pulmonary valve development,19/18493,0.016319156,0.040987648,0.014706216,4846,NOS3,0.012339157,1
BP,GO:0010523,negative regulation of calcium ion transport into cytosol,19/18493,0.016319156,0.040987648,0.014706216,596,BCL2,0.005903428,1
BP,GO:0010888,negative regulation of lipid storage,19/18493,0.016319156,0.040987648,0.014706216,5468,PPARG,0.010989006,1
BP,GO:0071636,positive regulation of transforming growth factor beta production,19/18493,0.016319156,0.040987648,0.014706216,5743,PTGS2,0.015701529,1
BP,GO:1902003,regulation of amyloid-beta formation,19/18493,0.016319156,0.040987648,0.014706216,351,APP,0.01631653,1
BP,GO:1905288,vascular associated smooth muscle cell apoptotic process,19/18493,0.016319156,0.040987648,0.014706216,5468,PPARG,0.010989006,1
BP,GO:1905459,regulation of vascular associated smooth muscle cell apoptotic process,19/18493,0.016319156,0.040987648,0.014706216,5468,PPARG,0.010989006,1
BP,GO:0033157,regulation of intracellular protein transport,232/18493,0.016749274,0.042006887,0.015071915,2932/5743,"GSK3B,PTGS2",0.026812531,2
BP,GO:0003323,type B pancreatic cell development,20/18493,0.017171105,0.04220721,0.015143791,2932,GSK3B,0.011214877,1
BP,GO:0006582,melanin metabolic process,20/18493,0.017171105,0.04220721,0.015143791,596,BCL2,0.005849244,1
BP,GO:0007617,mating behavior,20/18493,0.017171105,0.04220721,0.015143791,351,APP,0.01616677,1
BP,GO:0010869,regulation of receptor biosynthetic process,20/18493,0.017171105,0.04220721,0.015143791,5468,PPARG,0.010888145,1
BP,GO:0030220,platelet formation,20/18493,0.017171105,0.04220721,0.015143791,836,CASP3,0.020379069,1
BP,GO:0032928,regulation of superoxide anion generation,20/18493,0.017171105,0.04220721,0.015143791,4137,MAPT,0.011056465,1
BP,GO:0034393,positive regulation of smooth muscle cell apoptotic process,20/18493,0.017171105,0.04220721,0.015143791,5468,PPARG,0.010888145,1
BP,GO:0034643,"establishment of mitochondrion localization, microtubule-mediated",20/18493,0.017171105,0.04220721,0.015143791,4137,MAPT,0.011056465,1
BP,GO:0045723,positive regulation of fatty acid biosynthetic process,20/18493,0.017171105,0.04220721,0.015143791,5743,PTGS2,0.015557413,1
BP,GO:0046697,decidualization,20/18493,0.017171105,0.04220721,0.015143791,5743,PTGS2,0.015557413,1
BP,GO:0047497,mitochondrion transport along microtubule,20/18493,0.017171105,0.04220721,0.015143791,4137,MAPT,0.011056465,1
BP,GO:0070584,mitochondrion morphogenesis,20/18493,0.017171105,0.04220721,0.015143791,581,BAX,0.007273277,1
BP,GO:0140131,positive regulation of lymphocyte chemotaxis,20/18493,0.017171105,0.04220721,0.015143791,102,ADAM10,0.009029956,1
BP,GO:2000310,regulation of NMDA receptor activity,20/18493,0.017171105,0.04220721,0.015143791,351,APP,0.01616677,1
BP,GO:0033002,muscle cell proliferation,236/18493,0.017298314,0.042459497,0.01523431,5743/5468,"PTGS2,PPARG",0.026395765,2
BP,GO:0034329,cell junction assembly,238/18493,0.017575722,0.043079217,0.015456663,1636/596,"ACE,BCL2",0.01652457,2
BP,GO:0003180,aortic valve morphogenesis,21/18493,0.018022361,0.043495307,0.015605955,4846,NOS3,0.012109784,1
BP,GO:0021854,hypothalamus development,21/18493,0.018022361,0.043495307,0.015605955,581,BAX,0.007204197,1
BP,GO:0035357,peroxisome proliferator activated receptor signaling pathway,21/18493,0.018022361,0.043495307,0.015605955,5468,PPARG,0.010784732,1
BP,GO:0036344,platelet morphogenesis,21/18493,0.018022361,0.043495307,0.015605955,836,CASP3,0.020185513,1
BP,GO:0042135,neurotransmitter catabolic process,21/18493,0.018022361,0.043495307,0.015605955,43,ACHE,0.009794303,1
BP,GO:0043369,"CD4-positive or CD8-positive, alpha-beta T cell lineage commitment",21/18493,0.018022361,0.043495307,0.015605955,596,BCL2,0.005793689,1
BP,GO:0046827,positive regulation of protein export from nucleus,21/18493,0.018022361,0.043495307,0.015605955,2932,GSK3B,0.01110836,1
BP,GO:0051900,regulation of mitochondrial depolarization,21/18493,0.018022361,0.043495307,0.015605955,596,BCL2,0.005793689,1
BP,GO:0055093,response to hyperoxia,21/18493,0.018022361,0.043495307,0.015605955,5468,PPARG,0.010784732,1
BP,GO:0071498,cellular response to fluid shear stress,21/18493,0.018022361,0.043495307,0.015605955,5743,PTGS2,0.015409653,1
BP,GO:1904886,beta-catenin destruction complex disassembly,21/18493,0.018022361,0.043495307,0.015605955,2932,GSK3B,0.01110836,1
BP,GO:0043543,protein acylation,242/18493,0.018136284,0.043709203,0.0156827,4137/2932,"MAPT,GSK3B",0.022025295,2
BP,GO:0033673,negative regulation of kinase activity,244/18493,0.018419424,0.0442681,0.01588323,4137/836,"MAPT,CASP3",0.030962056,2
BP,GO:0060047,heart contraction,244/18493,0.018419424,0.0442681,0.01588323,1636/4846,"ACE,NOS3",0.022662133,2
BP,GO:0022898,regulation of transmembrane transporter activity,245/18493,0.018561706,0.044486307,0.015961522,351/596,"APP,BCL2",0.021650209,2
BP,GO:0050730,regulation of peptidyl-tyrosine phosphorylation,245/18493,0.018561706,0.044486307,0.015961522,351/1636,"APP,ACE",0.026501776,2
BP,GO:0008053,mitochondrial fusion,22/18493,0.018872926,0.044858895,0.016095206,581,BAX,0.007133263,1
BP,GO:0009651,response to salt stress,22/18493,0.018872926,0.044858895,0.016095206,581,BAX,0.007133263,1
BP,GO:0070841,inclusion body assembly,22/18493,0.018872926,0.044858895,0.016095206,4137,MAPT,0.010843623,1
BP,GO:0071379,cellular response to prostaglandin stimulus,22/18493,0.018872926,0.044858895,0.016095206,5468,PPARG,0.010678543,1
BP,GO:0071425,hematopoietic stem cell proliferation,22/18493,0.018872926,0.044858895,0.016095206,1636,ACE,0.01057521,1
BP,GO:1903429,regulation of cell maturation,22/18493,0.018872926,0.044858895,0.016095206,596,BCL2,0.005736643,1
BP,GO:0006352,"DNA-templated transcription, initiation",248/18493,0.018991389,0.045078462,0.016173985,581/5468,"BAX,PPARG",0.01778379,2
BP,GO:0010951,negative regulation of endopeptidase activity,250/18493,0.019280201,0.045684987,0.016391604,351/5743,"APP,PTGS2",0.030930582,2
BP,GO:0090596,sensory organ morphogenesis,251/18493,0.019425312,0.045684987,0.016391604,596/581,"BCL2,BAX",0.012794252,2
BP,GO:0003015,heart process,252/18493,0.019570891,0.045684987,0.016391604,1636/4846,"ACE,NOS3",0.022433109,2
BP,GO:0090257,regulation of muscle system process,252/18493,0.019570891,0.045684987,0.016391604,4846/5743,"NOS3,PTGS2",0.027088299,2
BP,GO:0007413,axonal fasciculation,23/18493,0.019722801,0.045684987,0.016391604,836,CASP3,0.019869273,1
BP,GO:0010226,response to lithium ion,23/18493,0.019722801,0.045684987,0.016391604,5743,PTGS2,0.015168235,1
BP,GO:0030318,melanocyte differentiation,23/18493,0.019722801,0.045684987,0.016391604,596,BCL2,0.005702921,1
BP,GO:0032799,low-density lipoprotein receptor particle metabolic process,23/18493,0.019722801,0.045684987,0.016391604,5468,PPARG,0.010615771,1
BP,GO:0034695,response to prostaglandin E,23/18493,0.019722801,0.045684987,0.016391604,5468,PPARG,0.010615771,1
BP,GO:0036037,"CD8-positive, alpha-beta T cell activation",23/18493,0.019722801,0.045684987,0.016391604,596,BCL2,0.005702921,1
BP,GO:0051654,establishment of mitochondrion localization,23/18493,0.019722801,0.045684987,0.016391604,4137,MAPT,0.01077988,1
BP,GO:0051882,mitochondrial depolarization,23/18493,0.019722801,0.045684987,0.016391604,596,BCL2,0.005702921,1
BP,GO:0071404,cellular response to low-density lipoprotein particle stimulus,23/18493,0.019722801,0.045684987,0.016391604,5468,PPARG,0.010615771,1
BP,GO:0090140,regulation of mitochondrial fission,23/18493,0.019722801,0.045684987,0.016391604,4137,MAPT,0.01077988,1
BP,GO:0106030,neuron projection fasciculation,23/18493,0.019722801,0.045684987,0.016391604,836,CASP3,0.019869273,1
BP,GO:1901889,negative regulation of cell junction assembly,23/18493,0.019722801,0.045684987,0.016391604,1636,ACE,0.010513045,1
BP,GO:1901984,negative regulation of protein acetylation,23/18493,0.019722801,0.045684987,0.016391604,2932,GSK3B,0.010934329,1
BP,GO:1902254,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,23/18493,0.019722801,0.045684987,0.016391604,596,BCL2,0.005702921,1
BP,GO:0007281,germ cell development,255/18493,0.020010433,0.046227311,0.016586188,596/581,"BCL2,BAX",0.012745326,2
BP,GO:0051091,positive regulation of DNA-binding transcription factor activity,255/18493,0.020010433,0.046227311,0.016586188,351/5468,"APP,PPARG",0.026277246,2
BP,GO:0006164,purine nucleotide biosynthetic process,258/18493,0.020454164,0.046651431,0.016738361,4846/4843,"NOS3,NOS2",0.020717273,2
BP,GO:0001516,prostaglandin biosynthetic process,24/18493,0.020571985,0.046651431,0.016738361,5743,PTGS2,0.01506534,1
BP,GO:0001783,B cell apoptotic process,24/18493,0.020571985,0.046651431,0.016738361,581,BAX,0.007043227,1
BP,GO:0001919,regulation of receptor recycling,24/18493,0.020571985,0.046651431,0.016738361,43,ACHE,0.00957546,1
BP,GO:0002227,innate immune response in mucosa,24/18493,0.020571985,0.046651431,0.016738361,4843,NOS2,0.008878069,1
BP,GO:0003176,aortic valve development,24/18493,0.020571985,0.046651431,0.016738361,4846,NOS3,0.011839204,1
BP,GO:0031639,plasminogen activation,24/18493,0.020571985,0.046651431,0.016738361,5328,PLAU,0.004900988,1
BP,GO:0043457,regulation of cellular respiration,24/18493,0.020571985,0.046651431,0.016738361,4843,NOS2,0.008878069,1
BP,GO:0046457,prostanoid biosynthetic process,24/18493,0.020571985,0.046651431,0.016738361,5743,PTGS2,0.01506534,1
BP,GO:0060561,apoptotic process involved in morphogenesis,24/18493,0.020571985,0.046651431,0.016738361,581,BAX,0.007043227,1
BP,GO:1900739,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,24/18493,0.020571985,0.046651431,0.016738361,596,BCL2,0.005664235,1
BP,GO:1900740,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,24/18493,0.020571985,0.046651431,0.016738361,596,BCL2,0.005664235,1
BP,GO:1902991,regulation of amyloid precursor protein catabolic process,24/18493,0.020571985,0.046651431,0.016738361,351,APP,0.015655423,1
BP,GO:2000209,regulation of anoikis,24/18493,0.020571985,0.046651431,0.016738361,596,BCL2,0.005664235,1
BP,GO:0050851,antigen receptor-mediated signaling pathway,259/18493,0.020603001,0.046660531,0.016741626,596/581,"BCL2,BAX",0.012706654,2
BP,GO:0010466,negative regulation of peptidase activity,261/18493,0.020902061,0.047275865,0.016962405,351/5743,"APP,PTGS2",0.030587496,2
BP,GO:0000082,G1/S transition of mitotic cell cycle,263/18493,0.021202963,0.047760761,0.017136384,596/581,"BCL2,BAX",0.01261003,2
BP,GO:0002068,glandular epithelial cell development,25/18493,0.02142048,0.047760761,0.017136384,2932,GSK3B,0.010776887,1
BP,GO:0003309,type B pancreatic cell differentiation,25/18493,0.02142048,0.047760761,0.017136384,2932,GSK3B,0.010776887,1
BP,GO:0031069,hair follicle morphogenesis,25/18493,0.02142048,0.047760761,0.017136384,596,BCL2,0.005620806,1
BP,GO:0031116,positive regulation of microtubule polymerization,25/18493,0.02142048,0.047760761,0.017136384,4137,MAPT,0.010624662,1
BP,GO:0032461,positive regulation of protein oligomerization,25/18493,0.02142048,0.047760761,0.017136384,581,BAX,0.006989224,1
BP,GO:0035235,ionotropic glutamate receptor signaling pathway,25/18493,0.02142048,0.047760761,0.017136384,351,APP,0.015535388,1
BP,GO:0060330,regulation of response to interferon-gamma,25/18493,0.02142048,0.047760761,0.017136384,5468,PPARG,0.010462916,1
BP,GO:0060334,regulation of interferon-gamma-mediated signaling pathway,25/18493,0.02142048,0.047760761,0.017136384,5468,PPARG,0.010462916,1
BP,GO:0150077,regulation of neuroinflammatory response,25/18493,0.02142048,0.047760761,0.017136384,351,APP,0.015535388,1
BP,GO:1900101,regulation of endoplasmic reticulum unfolded protein response,25/18493,0.02142048,0.047760761,0.017136384,581,BAX,0.006989224,1
BP,GO:0016054,organic acid catabolic process,265/18493,0.021505701,0.04782735,0.017160276,4846/4843,"NOS3,NOS2",0.020549009,2
BP,GO:0046395,carboxylic acid catabolic process,265/18493,0.021505701,0.04782735,0.017160276,4846/4843,"NOS3,NOS2",0.020549009,2
BP,GO:0015980,energy derivation by oxidation of organic compounds,267/18493,0.021810268,0.048402009,0.017366462,2932/4843,"GSK3B,NOS2",0.019500998,2
BP,GO:0006836,neurotransmitter transport,268/18493,0.021963236,0.048402009,0.017366462,2932/23621,"GSK3B,BACE1",0.021655947,2
BP,GO:0007018,microtubule-based movement,269/18493,0.022116659,0.048402009,0.017366462,351/4137,"APP,MAPT",0.02604534,2
BP,GO:0034504,protein localization to nucleus,269/18493,0.022116659,0.048402009,0.017366462,2932/5743,"GSK3B,PTGS2",0.025613907,2
BP,GO:0002360,T cell lineage commitment,26/18493,0.022268286,0.048402009,0.017366462,596,BCL2,0.005596159,1
BP,GO:0003081,regulation of systemic arterial blood pressure by renin-angiotensin,26/18493,0.022268286,0.048402009,0.017366462,1636,ACE,0.010316234,1
BP,GO:0031954,positive regulation of protein autophosphorylation,26/18493,0.022268286,0.048402009,0.017366462,1636,ACE,0.010316234,1
BP,GO:0033137,negative regulation of peptidyl-serine phosphorylation,26/18493,0.022268286,0.048402009,0.017366462,581,BAX,0.006958577,1
BP,GO:0042953,lipoprotein transport,26/18493,0.022268286,0.048402009,0.017366462,5468,PPARG,0.010417037,1
BP,GO:0043032,positive regulation of macrophage activation,26/18493,0.022268286,0.048402009,0.017366462,351,APP,0.015467266,1
BP,GO:0044872,lipoprotein localization,26/18493,0.022268286,0.048402009,0.017366462,5468,PPARG,0.010417037,1
BP,GO:0045736,negative regulation of cyclin-dependent protein serine/threonine kinase activity,26/18493,0.022268286,0.048402009,0.017366462,836,CASP3,0.019497308,1
BP,GO:0048169,regulation of long-term neuronal synaptic plasticity,26/18493,0.022268286,0.048402009,0.017366462,351,APP,0.015467266,1
BP,GO:0048668,collateral sprouting,26/18493,0.022268286,0.048402009,0.017366462,351,APP,0.015467266,1
BP,GO:0048753,pigment granule organization,26/18493,0.022268286,0.048402009,0.017366462,596,BCL2,0.005596159,1
BP,GO:0050974,detection of mechanical stimulus involved in sensory perception,26/18493,0.022268286,0.048402009,0.017366462,23621,BACE1,0.010926315,1
BP,GO:0070168,negative regulation of biomineral tissue development,26/18493,0.022268286,0.048402009,0.017366462,4846,NOS3,0.011696913,1
BP,GO:1901623,regulation of lymphocyte chemotaxis,26/18493,0.022268286,0.048402009,0.017366462,102,ADAM10,0.008639248,1
BP,GO:0072522,purine-containing compound biosynthetic process,271/18493,0.022424866,0.048681116,0.017466604,4846/4843,"NOS3,NOS2",0.020429415,2
BP,GO:0007176,regulation of epidermal growth factor-activated receptor activity,27/18493,0.023115402,0.049557587,0.017781079,351,APP,0.015346755,1
BP,GO:0010575,positive regulation of vascular endothelial growth factor production,27/18493,0.023115402,0.049557587,0.017781079,5743,PTGS2,0.014768306,1
BP,GO:0010818,T cell chemotaxis,27/18493,0.023115402,0.049557587,0.017781079,102,ADAM10,0.008571936,1
BP,GO:0035883,enteroendocrine cell differentiation,27/18493,0.023115402,0.049557587,0.017781079,2932,GSK3B,0.010646033,1
BP,GO:0035902,response to immobilization stress,27/18493,0.023115402,0.049557587,0.017781079,5468,PPARG,0.010335873,1
BP,GO:0045932,negative regulation of muscle contraction,27/18493,0.023115402,0.049557587,0.017781079,5743,PTGS2,0.014768306,1
BP,GO:0048710,regulation of astrocyte differentiation,27/18493,0.023115402,0.049557587,0.017781079,351,APP,0.015346755,1
BP,GO:1904030,negative regulation of cyclin-dependent protein kinase activity,27/18493,0.023115402,0.049557587,0.017781079,836,CASP3,0.019345396,1
BP,GO:1905563,negative regulation of vascular endothelial cell proliferation,27/18493,0.023115402,0.049557587,0.017781079,5468,PPARG,0.010335873,1
BP,GO:1990776,response to angiotensin,27/18493,0.023115402,0.049557587,0.017781079,5743,PTGS2,0.014768306,1
BP,GO:0007162,negative regulation of cell adhesion,276/18493,0.023203291,0.049684369,0.017826568,836/102,"CASP3,ADAM10",0.027893593,2
BP,GO:0051146,striated muscle cell differentiation,277/18493,0.023360324,0.049958714,0.017925001,836/596,"CASP3,BCL2",0.024831151,2
CC,GO:0045121,membrane raft,304/19659,9.15E-08,4.60E-06,2.42E-06,351/4137/836/23621/4846/5743,"APP,MAPT,CASP3,BACE1,NOS3,PTGS2",0.337036172,6
CC,GO:0098857,membrane microdomain,305/19659,9.33E-08,4.60E-06,2.42E-06,351/4137/836/23621/4846/5743,"APP,MAPT,CASP3,BACE1,NOS3,PTGS2",0.337036172,6
CC,GO:0098589,membrane region,316/19659,1.15E-07,4.60E-06,2.42E-06,351/4137/836/23621/4846/5743,"APP,MAPT,CASP3,BACE1,NOS3,PTGS2",0.337036172,6
CC,GO:0005788,endoplasmic reticulum lumen,301/19659,8.48E-05,0.002263151,0.001191132,351/23621/102/5743,"APP,BACE1,ADAM10,PTGS2",0.100404049,4
CC,GO:0046930,pore complex,18/19659,9.43E-05,0.002263151,0.001191132,596/581,"BCL2,BAX",0.025252793,2
CC,GO:0097386,glial cell projection,23/19659,0.000155561,0.003111219,0.001637484,351/4137,"APP,MAPT",0.049650718,2
CC,GO:0043197,dendritic spine,164/19659,0.000294717,0.004580931,0.002411017,351/4137/102,"APP,MAPT,ADAM10",0.061688538,3
CC,GO:0044309,neuron spine,166/19659,0.000305395,0.004580931,0.002411017,351/4137/102,"APP,MAPT,ADAM10",0.061688538,3
CC,GO:0005798,Golgi-associated vesicle,175/19659,0.000356548,0.004753979,0.002502094,351/23621/102,"APP,BACE1,ADAM10",0.06187894,3
CC,GO:0043025,neuronal cell body,483/19659,0.000517827,0.006213924,0.003270486,4137/836/23621/102,"MAPT,CASP3,BACE1,ADAM10",0.083291272,4
CC,GO:0005802,trans-Golgi network,225/19659,0.000742048,0.008095069,0.004260562,351/23621/102,"APP,BACE1,ADAM10",0.055721173,3
CC,GO:0044304,main axon,68/19659,0.001371074,0.013710738,0.007216178,351/4137,"APP,MAPT",0.036894178,2
CC,GO:0070821,tertiary granule membrane,73/19659,0.001577984,0.014028716,0.007383535,5328/102,"PLAU,ADAM10",0.018994732,2
CC,GO:0031594,neuromuscular junction,76/19659,0.001708852,0.014028716,0.007383535,351/43,"APP,ACHE",0.035122188,2
CC,GO:0005901,caveola,77/19659,0.00175359,0.014028716,0.007383535,4846/5743,"NOS3,PTGS2",0.037451977,2
CC,GO:0060205,cytoplasmic vesicle lumen,338/19659,0.002388849,0.01625301,0.008554216,351/23621/4353,"APP,BACE1,MPO",0.048900183,3
CC,GO:0031983,vesicle lumen,339/19659,0.00240898,0.01625301,0.008554216,351/23621/4353,"APP,BACE1,MPO",0.048900183,3
CC,GO:0035579,specific granule membrane,91/19659,0.002437952,0.01625301,0.008554216,5328/102,"PLAU,ADAM10",0.018339537,2
CC,GO:0044853,plasma membrane raft,102/19659,0.003050693,0.019267537,0.010140809,4846/5743,"NOS3,PTGS2",0.034666633,2
CC,GO:0005635,nuclear envelope,461/19659,0.005714863,0.034289181,0.018046937,351/596/581,"APP,BCL2,BAX",0.031211838,3
CC,GO:0098793,presynapse,482/19659,0.006465918,0.036048323,0.018972802,351/23621/102,"APP,BACE1,ADAM10",0.038441938,3
CC,GO:0042581,specific granule,160/19659,0.007329346,0.036048323,0.018972802,5328/102,"PLAU,ADAM10",0.014793225,2
CC,GO:0070820,tertiary granule,164/19659,0.007687011,0.036048323,0.018972802,5328/102,"PLAU,ADAM10",0.014793225,2
CC,GO:0030426,growth cone,165/19659,0.007777649,0.036048323,0.018972802,351/4137,"APP,MAPT",0.028579859,2
CC,GO:0030427,site of polarized growth,167/19659,0.007960385,0.036048323,0.018972802,351/4137,"APP,MAPT",0.028579859,2
CC,GO:0035253,ciliary rootlet,10/19659,0.008110873,0.036048323,0.018972802,351,APP,0.016972414,1
CC,GO:1990909,Wnt signalosome,10/19659,0.008110873,0.036048323,0.018972802,2932,GSK3B,0.011773751,1
CC,GO:0005741,mitochondrial outer membrane,180/19659,0.00919526,0.037647594,0.019814523,596/581,"BCL2,BAX",0.013596491,2
CC,GO:0008021,synaptic vesicle,180/19659,0.00919526,0.037647594,0.019814523,23621/102,"BACE1,ADAM10",0.021189056,2
CC,GO:0030877,beta-catenin destruction complex,12/19659,0.009725629,0.037647594,0.019814523,2932,GSK3B,0.011619945,1
CC,GO:0097449,astrocyte projection,12/19659,0.009725629,0.037647594,0.019814523,351,APP,0.016750695,1
CC,GO:0070382,exocytic vesicle,197/19659,0.010931231,0.04047714,0.021303758,23621/102,"BACE1,ADAM10",0.020720832,2
CC,GO:0043083,synaptic cleft,14/19659,0.01133792,0.04047714,0.021303758,43,ACHE,0.010018974,1
CC,GO:0031968,organelle outer membrane,204/19659,0.011685186,0.04047714,0.021303758,596/581,"BCL2,BAX",0.013296043,2
CC,GO:0019867,outer membrane,206/19659,0.01190474,0.04047714,0.021303758,596/581,"BCL2,BAX",0.013296043,2
CC,GO:0030673,axolemma,15/19659,0.012143142,0.04047714,0.021303758,4137,MAPT,0.011202667,1
CC,GO:0097038,perinuclear endoplasmic reticulum,16/19659,0.012947749,0.041992701,0.022101422,102,ADAM10,0.009044492,1
CC,GO:0090723,growth cone part,17/19659,0.013751743,0.043426555,0.022856082,351,APP,0.016021302,1
MF,GO:0020037,heme binding,131/17632,4.94E-06,0.00050635,0.000184634,4846/4353/4843/5743,"NOS3,MPO,NOS2,PTGS2",0.112526523,4
MF,GO:0046906,tetrapyrrole binding,141/17632,6.62E-06,0.00050635,0.000184634,4846/4353/4843/5743,"NOS3,MPO,NOS2,PTGS2",0.112526523,4
MF,GO:0051400,BH domain binding,10/17632,3.46E-05,0.001323235,0.000482501,596/581,"BCL2,BAX",0.02747782,2
MF,GO:0070513,death domain binding,10/17632,3.46E-05,0.001323235,0.000482501,596/581,"BCL2,BAX",0.02747782,2
MF,GO:0034452,dynactin binding,12/17632,5.07E-05,0.001526645,0.000556671,4137/2932,"MAPT,GSK3B",0.04562878,2
MF,GO:0016653,"oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor",13/17632,5.99E-05,0.001526645,0.000556671,4846/4843,"NOS3,NOS2",0.043831217,2
MF,GO:0010181,FMN binding,15/17632,8.05E-05,0.001759649,0.000641633,4846/4843,"NOS3,NOS2",0.042871127,2
MF,GO:0002020,protease binding,125/17632,0.000182082,0.003445854,0.001256486,836/2932/596,"CASP3,GSK3B,BCL2",0.067081742,3
MF,GO:0019903,protein phosphatase binding,133/17632,0.000218677,0.003445854,0.001256486,4137/596/5468,"MAPT,BCL2,PPARG",0.049794372,3
MF,GO:0004190,aspartic-type endopeptidase activity,25/17632,0.000228805,0.003445854,0.001256486,836/23621,"CASP3,BACE1",0.056970775,2
MF,GO:0070001,aspartic-type peptidase activity,26/17632,0.000247741,0.003445854,0.001256486,836/23621,"CASP3,BACE1",0.056970775,2
MF,GO:0051721,protein phosphatase 2A binding,29/17632,0.000308995,0.003939685,0.001436555,4137/596,"MAPT,BCL2",0.029572263,2
MF,GO:0016705,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen",161/17632,0.000383456,0.004512978,0.001645599,4846/4843/5743,"NOS3,NOS2,PTGS2",0.06305103,3
MF,GO:0019902,phosphatase binding,178/17632,0.000514267,0.005364347,0.00195604,4137/596/5468,"MAPT,BCL2,PPARG",0.045907799,3
MF,GO:0016504,peptidase activator activity,39/17632,0.000560978,0.005364347,0.00195604,351/836,"APP,CASP3",0.060363672,2
MF,GO:0016709,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen",39/17632,0.000560978,0.005364347,0.00195604,4846/4843,"NOS3,NOS2",0.035336925,2
MF,GO:0031406,carboxylic acid binding,192/17632,0.000641213,0.005770918,0.002104291,4846/4843/5468,"NOS3,NOS2,PPARG",0.052576029,3
MF,GO:0043177,organic acid binding,204/17632,0.000764723,0.006500149,0.002370195,4846/4843/5468,"NOS3,NOS2,PPARG",0.051362388,3
MF,GO:0048037,cofactor binding,495/17632,0.000853722,0.006874711,0.002506775,4846/4353/4843/5743,"NOS3,MPO,NOS2,PTGS2",0.07384694,4
MF,GO:0050661,NADP binding,50/17632,0.000922011,0.007053385,0.002571926,4846/4843,"NOS3,NOS2",0.033486712,2
MF,GO:0004601,peroxidase activity,52/17632,0.000996975,0.007263673,0.002648605,4353/5743,"MPO,PTGS2",0.039742672,2
MF,GO:0043621,protein self-association,55/17632,0.001114751,0.007686103,0.002802638,43/5468,"ACHE,PPARG",0.031956141,2
MF,GO:0016684,"oxidoreductase activity, acting on peroxide as acceptor",56/17632,0.001155427,0.007686103,0.002802638,4353/5743,"MPO,PTGS2",0.039286501,2
MF,GO:0016597,amino acid binding,59/17632,0.00128169,0.008170771,0.002979366,4846/4843,"NOS3,NOS2",0.032492734,2
MF,GO:0001540,amyloid-beta binding,61/17632,0.001369382,0.008380618,0.003055884,23621/43,"BACE1,ACHE",0.032192496,2
MF,GO:0017171,serine hydrolase activity,277/17632,0.001845774,0.010861669,0.003960567,1636/5328/43,"ACE,PLAU,ACHE",0.036767027,3
MF,GO:0042277,peptide binding,285/17632,0.002002076,0.011345098,0.004136844,23621/43/5468,"BACE1,ACHE,PPARG",0.045561166,3
MF,GO:0050660,flavin adenine dinucleotide binding,77/17632,0.002171072,0.011863356,0.00432582,4846/4843,"NOS3,NOS2",0.029972292,2
MF,GO:0016209,antioxidant activity,86/17632,0.002699115,0.014240159,0.00519249,4353/5743,"MPO,PTGS2",0.034310246,2
MF,GO:0004497,monooxygenase activity,98/17632,0.003487773,0.017405062,0.006346531,4846/4843,"NOS3,NOS2",0.027381448,2
MF,GO:0033218,amide binding,348/17632,0.003526516,0.017405062,0.006346531,23621/43/5468,"BACE1,ACHE,PPARG",0.041207697,3
MF,GO:0051087,chaperone binding,101/17632,0.003699844,0.01768988,0.006450386,4137/581,"MAPT,BAX",0.023365662,2
MF,GO:0016651,"oxidoreductase activity, acting on NAD(P)H",107/17632,0.004141668,0.019202279,0.007001863,4846/4843,"NOS3,NOS2",0.026717237,2
MF,GO:0008238,exopeptidase activity,113/17632,0.004606869,0.020730912,0.007559259,1636/23621,"ACE,BACE1",0.027190572,2
MF,GO:0031072,heat shock protein binding,115/17632,0.004767091,0.020838997,0.007598671,4137/581,"MAPT,BAX",0.022416888,2
MF,GO:0017124,SH3 domain binding,127/17632,0.005781937,0.024573232,0.008960312,4137/102,"MAPT,ADAM10",0.023519233,2
MF,GO:0001085,RNA polymerase II transcription factor binding,140/17632,0.00698332,0.02887697,0.010529614,2932/5468,"GSK3B,PPARG",0.024753477,2
MF,GO:0003680,AT DNA binding,10/17632,0.009039742,0.035463605,0.012931345,4137,MAPT,0.011664571,1
MF,GO:0004954,prostanoid receptor activity,10/17632,0.009039742,0.035463605,0.012931345,5468,PPARG,0.011486993,1
MF,GO:0008201,heparin binding,163/17632,0.009361639,0.035808269,0.013057023,351/4353,"APP,MPO",0.027509997,2
MF,GO:0016004,phospholipase activator activity,11/17632,0.009939491,0.03709127,0.013524853,836,CASP3,0.021210991,1
MF,GO:0004861,cyclin-dependent protein serine/threonine kinase inhibitor activity,12/17632,0.010838473,0.037640311,0.013725053,836,CASP3,0.021116383,1
MF,GO:0008239,dipeptidyl-peptidase activity,12/17632,0.010838473,0.037640311,0.013725053,1636,ACE,0.011172904,1
MF,GO:0031404,chloride ion binding,13/17632,0.01173669,0.037640311,0.013725053,1636,ACE,0.011172904,1
MF,GO:0034236,protein kinase A catalytic subunit binding,13/17632,0.01173669,0.037640311,0.013725053,2932,GSK3B,0.01162063,1
MF,GO:0036041,long-chain fatty acid binding,13/17632,0.01173669,0.037640311,0.013725053,5468,PPARG,0.011282077,1
MF,GO:0060229,lipase activator activity,13/17632,0.01173669,0.037640311,0.013725053,836,CASP3,0.021116383,1
MF,GO:0008237,metallopeptidase activity,189/17632,0.01242555,0.037640311,0.013725053,1636/102,"ACE,ADAM10",0.020529563,2
MF,GO:0004953,icosanoid receptor activity,14/17632,0.012634142,0.037640311,0.013725053,5468,PPARG,0.011282077,1
MF,GO:0031434,mitogen-activated protein kinase kinase binding,14/17632,0.012634142,0.037640311,0.013725053,1636,ACE,0.011172904,1
MF,GO:0005516,calmodulin binding,192/17632,0.012803948,0.037640311,0.013725053,4846/4843,"NOS3,NOS2",0.022167985,2
MF,GO:0008242,omega peptidase activity,15/17632,0.013530831,0.037640311,0.013725053,23621,BACE1,0.011833647,1
MF,GO:0046965,retinoid X receptor binding,15/17632,0.013530831,0.037640311,0.013725053,5468,PPARG,0.011282077,1
MF,GO:0050321,tau-protein kinase activity,15/17632,0.013530831,0.037640311,0.013725053,2932,GSK3B,0.01162063,1
MF,GO:0097153,cysteine-type endopeptidase activity involved in apoptotic process,15/17632,0.013530831,0.037640311,0.013725053,836,CASP3,0.021116383,1
MF,GO:0016805,dipeptidase activity,16/17632,0.014426755,0.038724449,0.01412037,1636,ACE,0.011076168,1
MF,GO:0034185,apolipoprotein binding,16/17632,0.014426755,0.038724449,0.01412037,4137,MAPT,0.011357296,1
MF,GO:0005123,death receptor binding,17/17632,0.015321917,0.039070889,0.014246695,836,CASP3,0.020876211,1
MF,GO:0008656,cysteine-type endopeptidase activator activity involved in apoptotic process,17/17632,0.015321917,0.039070889,0.014246695,836,CASP3,0.020876211,1
MF,GO:0042166,acetylcholine binding,17/17632,0.015321917,0.039070889,0.014246695,43,ACHE,0.01012944,1
MF,GO:0061134,peptidase regulator activity,220/17632,0.01657563,0.04157494,0.015159765,351/836,"APP,CASP3",0.036720113,2
MF,GO:0005539,glycosaminoglycan binding,222/17632,0.016861302,0.041609341,0.015172309,351/4353,"APP,MPO",0.026269446,2
MF,GO:0016505,peptidase activator activity involved in apoptotic process,20/17632,0.018002832,0.043721163,0.015942357,836,CASP3,0.020152167,1
MF,GO:1901681,sulfur compound binding,242/17632,0.019833792,0.04741516,0.017289326,351/4353,"APP,MPO",0.025190245,2
